Classification scheme for severity of frostbite injuries.
\\n\\n
Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\\n\\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\\n"}]',published:!0,mainMedia:null},components:[{type:"htmlEditorComponent",content:'IntechOpen is proud to announce that 191 of our authors have made the Clarivate™ Highly Cited Researchers List for 2020, ranking them among the top 1% most-cited.
\n\nThroughout the years, the list has named a total of 261 IntechOpen authors as Highly Cited. Of those researchers, 69 have been featured on the list multiple times.
\n\n\n\nReleased this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\n\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\n'}],latestNews:[{slug:"intechopen-signs-new-contract-with-cepiec-china-for-distribution-of-open-access-books-20210319",title:"IntechOpen Signs New Contract with CEPIEC, China for Distribution of Open Access Books"},{slug:"150-million-downloads-and-counting-20210316",title:"150 Million Downloads and Counting"},{slug:"intechopen-secures-indefinite-content-preservation-with-clockss-20210309",title:"IntechOpen Secures Indefinite Content Preservation with CLOCKSS"},{slug:"intechopen-expands-to-all-global-amazon-channels-with-full-catalog-of-books-20210308",title:"IntechOpen Expands to All Global Amazon Channels with Full Catalog of Books"},{slug:"stanford-university-identifies-top-2-scientists-over-1-000-are-intechopen-authors-and-editors-20210122",title:"Stanford University Identifies Top 2% Scientists, Over 1,000 are IntechOpen Authors and Editors"},{slug:"intechopen-authors-included-in-the-highly-cited-researchers-list-for-2020-20210121",title:"IntechOpen Authors Included in the Highly Cited Researchers List for 2020"},{slug:"intechopen-maintains-position-as-the-world-s-largest-oa-book-publisher-20201218",title:"IntechOpen Maintains Position as the World’s Largest OA Book Publisher"},{slug:"all-intechopen-books-available-on-perlego-20201215",title:"All IntechOpen Books Available on Perlego"}]},book:{item:{type:"book",id:"6588",leadTitle:null,fullTitle:"Plasmid",title:"Plasmid",subtitle:null,reviewType:"peer-reviewed",abstract:"This book captures in a single volume the wealth of information on the plasmid structure, function, and biology of all organisms that have been examined to date. Plasmids exhibit wide variations in size, modes of replication and transmission, host ranges, and the genes they carry and have provided us with a great understanding of basic life principles at the molecular level. Written by experts in the field, this book is a valuable source of up-to-date information, delivering the latest impacts on studies in the areas of plasmid types, genomes, purification analysis, and expression of recombinant proteins in bacteria. Plasmid utilization in the synthesis of plasmid-based vaccines, plasmids as genetic tools, and their applications in ecology and the evolutionary process are also covered. This book is a single source of valuable information for instructors and students in advanced undergraduate and graduate courses on plasmids. It will also appeal to researchers seeking to find new relationships between biological processes that are linked by plasmids to the environment.",isbn:"978-1-83880-238-7",printIsbn:"978-1-83880-237-0",pdfIsbn:"978-1-83881-126-6",doi:"10.5772/intechopen.71424",price:100,priceEur:109,priceUsd:129,slug:"plasmid",numberOfPages:70,isOpenForSubmission:!1,isInWos:1,hash:"7411c33be05d3ce296d294c3c01af404",bookSignature:"Munazza Gull",publishedDate:"June 19th 2019",coverURL:"https://cdn.intechopen.com/books/images_new/6588.jpg",numberOfDownloads:5916,numberOfWosCitations:3,numberOfCrossrefCitations:1,numberOfDimensionsCitations:5,hasAltmetrics:1,numberOfTotalCitations:9,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"December 13th 2017",dateEndSecondStepPublish:"January 10th 2018",dateEndThirdStepPublish:"March 4th 2018",dateEndFourthStepPublish:"May 23rd 2018",dateEndFifthStepPublish:"July 22nd 2018",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,editors:[{id:"186160",title:"Prof.",name:"Munazza",middleName:null,surname:"Gull",slug:"munazza-gull",fullName:"Munazza Gull",profilePictureURL:"https://mts.intechopen.com/storage/users/186160/images/6128_n.jpg",biography:"Dr. Munazza Gull is currently working as Associate Professor, in Biochemistry Department, Faculty of Science, King Abdul Aziz University, Jeddah, Kingdom of Saudi Arabia. She graduated (MSc. Plant Sciences) from University of Agriculture, Faisalabad, Pakistan in 1999. She received her M.Phil degree from the same university Plant Sciences Microbiology in 2002. She obtained her PhD in Biotechnology in 2008 and also worked as researcher from National Institute of Biotechnology and Genetic Engineering, Faisalabad ,Pakistan (NIBGE) /Quaid i-Azam University Islamabad, Pakistan. She has experience in Microbial biotechnology and genetics and is active in the following subjects: Biotechnology and sustainable Environment, Microbe-interactions, biopreparates/biostimulators/bioproducts studies. She previously worked with rhizobacteria, Biocontrol, Integrated disease management, Secondary metabolites/bioproducts/antimicrobial bioactive compounds. Now her research interests are focused on DNA/Protein finger printing in human disease management, Environmental/soil/water microorganisms and Phytological/Industrial/biomedical productivity.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"King Abdulaziz University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"421",title:"Molecular Genetics",slug:"biochemistry-genetics-and-molecular-biology-microbiology-molecular-genetics"}],chapters:[{id:"62243",title:"Introductory Chapter: Preface to Plasmids",doi:"10.5772/intechopen.78673",slug:"introductory-chapter-preface-to-plasmids",totalDownloads:584,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Munazza Gull and Sondos El-Baz",downloadPdfUrl:"/chapter/pdf-download/62243",previewPdfUrl:"/chapter/pdf-preview/62243",authors:[{id:"186160",title:"Prof.",name:"Munazza",surname:"Gull",slug:"munazza-gull",fullName:"Munazza Gull"},{id:"257939",title:"MSc.",name:"Sondos",surname:"El-Baz",slug:"sondos-el-baz",fullName:"Sondos El-Baz"}],corrections:null},{id:"60894",title:"Plasmid Purification",doi:"10.5772/intechopen.76226",slug:"plasmid-purification",totalDownloads:1860,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Noboru Sasagawa",downloadPdfUrl:"/chapter/pdf-download/60894",previewPdfUrl:"/chapter/pdf-preview/60894",authors:[{id:"240378",title:"Prof.",name:"Noboru",surname:"Sasagawa",slug:"noboru-sasagawa",fullName:"Noboru Sasagawa"}],corrections:null},{id:"65632",title:"Plasmids for Optimizing Expression of Recombinant Proteins in E. coli",doi:"10.5772/intechopen.82205",slug:"plasmids-for-optimizing-expression-of-recombinant-proteins-in-em-e-coli-em-",totalDownloads:1134,totalCrossrefCites:0,totalDimensionsCites:2,signatures:"Ahmed Mahmoud Al-Hejin, Roop Singh Bora and Mohamed Morsi M. Ahmed",downloadPdfUrl:"/chapter/pdf-download/65632",previewPdfUrl:"/chapter/pdf-preview/65632",authors:[{id:"260020",title:"Dr.",name:"Ahmed",surname:"AlHejin",slug:"ahmed-alhejin",fullName:"Ahmed AlHejin"}],corrections:null},{id:"61091",title:"Plasmid-Based DNA Vaccines",doi:"10.5772/intechopen.76754",slug:"plasmid-based-dna-vaccines",totalDownloads:1288,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Leonardo A. Gómez and Angel A. Oñate",downloadPdfUrl:"/chapter/pdf-download/61091",previewPdfUrl:"/chapter/pdf-preview/61091",authors:[{id:"240792",title:"Dr.",name:"Angel",surname:"Oñate",slug:"angel-onate",fullName:"Angel Oñate"}],corrections:null},{id:"66546",title:"Plasmids as Genetic Tools and Their Applications in Ecology and Evolution",doi:"10.5772/intechopen.85705",slug:"plasmids-as-genetic-tools-and-their-applications-in-ecology-and-evolution",totalDownloads:1056,totalCrossrefCites:1,totalDimensionsCites:1,signatures:"Huda Al Doghaither and Munazza Gull",downloadPdfUrl:"/chapter/pdf-download/66546",previewPdfUrl:"/chapter/pdf-preview/66546",authors:[{id:"186160",title:"Prof.",name:"Munazza",surname:"Gull",slug:"munazza-gull",fullName:"Munazza Gull"},{id:"288750",title:"Dr.",name:"Huda",surname:"Al Doghaither",slug:"huda-al-doghaither",fullName:"Huda Al Doghaither"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},relatedBooks:[{type:"book",id:"3302",title:"New Research Directions in DNA Repair",subtitle:null,isOpenForSubmission:!1,hash:"1370d613ce38c993753a3dd25f102a3c",slug:"new-research-directions-in-dna-repair",bookSignature:"Clark Chen",coverURL:"https://cdn.intechopen.com/books/images_new/3302.jpg",editedByType:"Edited by",editors:[{id:"62462",title:"Prof.",name:"Clark",surname:"Chen",slug:"clark-chen",fullName:"Clark Chen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3134",title:"The Mechanisms of DNA Replication",subtitle:null,isOpenForSubmission:!1,hash:"8f1c7fa7b94b35a862aa43cb4a29dea8",slug:"the-mechanisms-of-dna-replication",bookSignature:"David Stuart",coverURL:"https://cdn.intechopen.com/books/images_new/3134.jpg",editedByType:"Edited by",editors:[{id:"151937",title:"Dr.",name:"David",surname:"Stuart",slug:"david-stuart",fullName:"David Stuart"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"70783",slug:"corrigendum-to-spatial-analysis-of-the-erosive-hazard-of-soils-and-natural-risks-of-reservoir-siltat",title:"Corrigendum to: Spatial Analysis of the Erosive Hazard of Soils and Natural Risks of Reservoir Siltation",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/70783.pdf",downloadPdfUrl:"/chapter/pdf-download/70783",previewPdfUrl:"/chapter/pdf-preview/70783",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/70783",risUrl:"/chapter/ris/70783",chapter:{id:"69983",slug:"spatial-analysis-of-the-erosive-hazard-of-soils-and-natural-risks-of-reservoir-siltation",signatures:"Rabii El Gaatib and Abdelkader Larabi",dateSubmitted:"March 8th 2018",dateReviewed:"September 16th 2019",datePrePublished:"November 8th 2019",datePublished:"December 18th 2019",book:{id:"7300",title:"Soil Erosion",subtitle:"Rainfall Erosivity and Risk Assessment",fullTitle:"Soil Erosion - Rainfall Erosivity and Risk Assessment",slug:"soil-erosion-rainfall-erosivity-and-risk-assessment",publishedDate:"December 18th 2019",bookSignature:"Vlassios Hrissanthou and Konstantinos Kaffas",coverURL:"https://cdn.intechopen.com/books/images_new/7300.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"37707",title:"Prof.",name:"Vlassios",middleName:null,surname:"Hrissanthou",slug:"vlassios-hrissanthou",fullName:"Vlassios Hrissanthou"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"249619",title:"Dr.",name:"Rabii",middleName:null,surname:"El Gaatib",fullName:"Rabii El Gaatib",slug:"rabii-el-gaatib",email:"rabii_elgaatib@yahoo.fr",position:null,institution:null}]}},chapter:{id:"69983",slug:"spatial-analysis-of-the-erosive-hazard-of-soils-and-natural-risks-of-reservoir-siltation",signatures:"Rabii El Gaatib and Abdelkader Larabi",dateSubmitted:"March 8th 2018",dateReviewed:"September 16th 2019",datePrePublished:"November 8th 2019",datePublished:"December 18th 2019",book:{id:"7300",title:"Soil Erosion",subtitle:"Rainfall Erosivity and Risk Assessment",fullTitle:"Soil Erosion - Rainfall Erosivity and Risk Assessment",slug:"soil-erosion-rainfall-erosivity-and-risk-assessment",publishedDate:"December 18th 2019",bookSignature:"Vlassios Hrissanthou and Konstantinos Kaffas",coverURL:"https://cdn.intechopen.com/books/images_new/7300.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"37707",title:"Prof.",name:"Vlassios",middleName:null,surname:"Hrissanthou",slug:"vlassios-hrissanthou",fullName:"Vlassios Hrissanthou"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"249619",title:"Dr.",name:"Rabii",middleName:null,surname:"El Gaatib",fullName:"Rabii El Gaatib",slug:"rabii-el-gaatib",email:"rabii_elgaatib@yahoo.fr",position:null,institution:null}]},book:{id:"7300",title:"Soil Erosion",subtitle:"Rainfall Erosivity and Risk Assessment",fullTitle:"Soil Erosion - Rainfall Erosivity and Risk Assessment",slug:"soil-erosion-rainfall-erosivity-and-risk-assessment",publishedDate:"December 18th 2019",bookSignature:"Vlassios Hrissanthou and Konstantinos Kaffas",coverURL:"https://cdn.intechopen.com/books/images_new/7300.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"37707",title:"Prof.",name:"Vlassios",middleName:null,surname:"Hrissanthou",slug:"vlassios-hrissanthou",fullName:"Vlassios Hrissanthou"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"11017",leadTitle:null,title:"Herpesviridae - New Perspectives",subtitle:null,reviewType:"peer-reviewed",abstract:"\r\n\tHerpesviridae is a widespread family of double-stranded DNA viruses that infect mammals, which some members of this family are the etiological agent of different diseases in humans. Several host cells' lineages are susceptible to herpesvirus infection, e.g., epithelial cells, neurons, monocytes, lymphocytes. Noteworthy, the common characteristic of Herpesviruses is to establish latency in the host cell. This lifelong infection suggests that herpesviruses have critical features to evade immunosurveillance. The knowledge about herpesvirus molecular genetics has been critical to design new therapies based on Herpes simplex vectors.
\r\n\r\n\tThis book summarizes the main aspects of Herpesviruses infection, the key molecular mechanisms associated to latency and reactivation, mechanism related to immune evasion, immunosuppression and cellular stress, the contribution of herpesvirus (Herpes simplex type 1, Human herpevirus 6) to the neurodegenerative disease and autoimmunity, development of new drugs and vaccines against Herpesviruses, and development of gene therapy against cancer based on herpes simplex vectors.
\r\n\t
Genomic DNA is susceptible to a variety of mutagenic processes. The maintenance of the stability of genetic material, which is an important and essential feature of every living organism, depends on an accurate DNA replication [1]. Organisms across all kingdoms have developed diverse and highly efficient repair mechanisms to safeguard the genome from deleterious consequences of various kinds of stresses that might tend to destabilize the integrity of the genome. DNA is constantly being damaged. A low fidelity of DNA synthesis in various compartments of the cells by main replicative DNA polymerases leads to genomic instability (mutator phenotype) [2]. The errors produced during DNA synthesis could result from three fidelity determining processes: a)nucleotide misinsertion into the nascent DNA, b)lack of exonucleolytic proofreading activity, i.e the mechanism to identify and excise incorrect nucleotide incorporated during DNA synthesis, and c)extension of mismatched 3’-termini of DNA [3]. Failure to repair DNA can lead to mutations, genomic instability, chromosomal abnormalities, progression of cancer and premature aging.
Mutator phenotypes (with the potential for cancer progression) have been reported for cells that lack a proofreading 3’→5’ exonuclease activity associated with the DNA polymerase [4]. Certain organisms with a deficiency of exonucleolytic proofreading, have an increased susceptibility to cancer, especially under conditions of stress. Since cancer cells typically have many mutations compared to a non-cancer cell, it was proposed that one of the earliest changes in the development of a cancer cell is a mutation that increases the spontaneous mutation rate [5]. Inactivation of 3′→ 5′ exonuclease activity in the mouse DNA pol δ in nucleus appears to produce replication errors that can drive evolution of a cancer. Mitochondrial DNA (mtDNA) alterations have been associated with various human diseases with impaired mitochondrial function [6]. Mitochondrial DNA polymerase γ (pol γ) is responsible for replication of mtDNA and is implicated in all repair processes [7]. Mitochondrial DNA is prone to mutations, since it is localized near the inner mitochondrial membrane in which reactive oxygene species are generated. Additionally, mtDNA lacks histone protection and the highly efficient DNA repair mechanisms [8]. The mutation rate of mtDNA is estimated to be about 20-100-fold higher than that of nuclear DNA [9]. The mutagenic mechanisms were shown to be replication errors caused by misinsertion (as a result of a dNTP excess), or decreased proofreading efficiency [10,11]. The biological importance of the 3’→5’ exonuclease activity of pol γ to mtDNA integrity is illustrated by the fact that mice encoding an exonuclease-deficient form of pol γ have strongly elevated rates of base substitutions in mtDNA and undergo accelerated aging [12].
Virulence, pathogenesis and the ability to develop effective antiretroviral drugs and vaccines are largely dependent on genetic diversity in viruses [13]. Retroviruses are RNA viruses that replicate through a DNA intermediate in a process catalyzed by the viral reverse transcriptase (RT) in cytoplasm [14]. Human immunodeficiency virus type 1 (HIV-1), the etiological agent of AIDS, exhibits exceptionally high mutation frequencies [15]. The accepted explanations for the inaccuracy of HIV-1 RT are the relatively low fidelity of the enzyme during DNA synthesis and the deficiency of intrinsic 3′→5′ exonuclease activity [16-18]. A strong mutator phenotype is also observed for herpes viral DNA polymerase mutants with reduced intrinsic 3′→5′ exonuclease activity [19].
Thus, in various compartments of the cell increased DNA replication accuracy provided by DNA polymerase proofreading activity is an essential activity for the maintenance of genomic integrity for many organisms.
The effect of misinsertion of a wrong nucleotide on the polymerase reaction can be either inhibitory, leading to nascent chain termination and primer dissociation or non-inhibitory, leading to mispair extension (resulting in the fixation of either transition or transversion mutations) (Fig 1). Exonucleolytic proofreading of polymerization errors is one of the major determinants of genome stability [20]. The physiological role for the exonucleolytic proofreading has been proposed to be to increase the fidelity of DNA synthesis by excising incorrectly polymerized nucleotides. Following the incorporation of a non-complementary nucleotide at the 3′ end of the primer, exonucleolytic correction can occur by intrinsic exonuclease through intramolecular shuttling of the DNA substrate from the polymerase to the 3′→5′ exonucleolysis active site of the enzyme (
The outcomes of the misincorporation. DNA polymerases following a misincorporation of the wrong nucleotide, can either continue chain elongation beyond the mismatch or remove the mispaired terminus (if a proofreading exonuclease is associated with DNA replication machinery) or block the DNA synthesis by dissociating from the template-primer.
The tumor suppressor protein p53 represents a central factor for the maintenance of genome stability and for the suppression of cancer [27,28]. Under normal conditions within the cell p53 is present at low levels, but after exposure to various stress signals, the protein is stabilized and functionally activated by a series of post-translational modifications, resulting in p53 accumulation at nuclear and extranuclear sites [29,30]. The cellular level of p53 and the nature of DNA damage can dictate the response of the cell. As p53 is a pleiotropic regulator, it affects many processes. The biological outcomes of p53 functions as a sequence-specific transcription factor include cell cycle arrest, apoptosis or DNA repair [31]. Apparently, cell cycle arrest mediated by p53 in response to DNA damage allows time for the cells to repair DNA. If the cells are unable to repair DNA damage, apoptosis is triggered by a p53-dependent pathway to eliminate the cells that contained damaged DNA. These processes together ensure the integrity of the genome. p53 can affect DNA repair processes through its ability to transactivate genes involved in these processes [28]. Mutations in p53 are the most frequent molecular alterations detected in human cancers. The loss of the functional p53 may be responsible for genetic instability and the development of cancer [32].
Appropriate subcellular localization is critical for regulating function of p53. p53 is actively transported between the nucleus and cytoplasm. Furthermore, p53 translocates to mitochondria. The sub-cellular localization of p53 and the interaction with other cellular or viral proteins plays a central role in the regulation of its various biological activities [26]. p53 may modulate DNA repair through processes, which are independent of its transactivation function. p53 can directly interact with DNA repair related cellular factors including DNA polymerase β, AP endonuclease, Rad 51, and mammalian homologs of the RecQ helicase family and Wrn proteins [33-36]. In addition, full range of various intrinsic biochemical features of the p53 protein support its possible roles in DNA repair. After DNA damage: (a) p53 is able to recognize and bind sites of DNA damage, such as single-stranded (ss) DNA and double-stranded (ds) DNA ends [37,38], (b) p53 catalyzes DNA and RNA strand transfer and promotes the annealing of complementary DNA and RNA single-strands [39,40], (c) p53 binds insertion/deletion mismatches and bulges [41] and (d) it can bind DNA in a non-sequence-specific manner [42]. Evidence suggesting a direct role in DNA repair is supported by observations that (1) p53 increases transcription-coupled nucleotide excision repair [43]; (2) p53, like classical mismatch repair factors, checks the fidelity of homologous recombination processes by specific mismatch recognition [44]; (3) p53 can markedly stimulate base excision repair [33,45]; (4) p53 exhibits 3\'→ 5\' exonuclease activity and wild-type p53, but not mutant p53, enhanced the replication fidelity of various DNA polymerases in an
Highly purified p53 protein from different sources displays 3´→ 5´ exonuclease activity. p53 has no associated polymerase activity and catalyzes the excision of nucleotides from DNA exclusively in the 3 ’to 5’direction [46]. This activity is dependent on the presence of Mg2+ and is intrinsic to the wtp53, since no exonuclease activity was detected with mutant p53 protein,
p53 removes 3’-terminal nucleotides from various nucleic acids substrates: ssDNA, dsDNA RNA/DNA template-primer, ssRNA and dsRNA [46-52]. A unique property of p53 is its ability to excise nucleotides non-processively (on DNA <17 nucleotides) and processively (on DNA >17 nucleotides) [48]. The purified wtp53 exhibits all hallmarks of a genuine proofreading activity [49]. First, the protein shows a preference for degradation of ssDNA over dsDNA substrate. Second, on partial duplex structures, the p53 exonuclease activity displays a marked preference for excision of a mismatched versus a correctly paired 3´ terminus, which enables the protein to act as a proofreader. The intrinsic ability of p53 exonuclease to sequentially remove incorrect 3’ terminal nucleotides from DNA strands before primer extension is important for subsequent elongation of primers during error correction and renders the p53 protein essential in DNA replication, repair, and recombination. Third, p53 acts coordinately with the DNA polymerase to enhance the fidelity of DNA synthesis by excision of mismatched nucleotides from the nascent DNA strand.
The proofreading capacity of p53 was observed during ongoing DNA synthesis
p53 is capable of excising 3\'-terminal mispaired nucleotides in direct exonuclease assay independent of DNA polymerase; p53 is very active when first binding to a 3’-terminus [49,50].. Some template-primers with terminal mispairs remain unextended by the polymerase. Interestingly, unextended free template-primers (already dissociated from the enzyme following the misinsertion) may be further recognized by other DNA polymerase (
p53 intrinsic exonuclease activity, like sequence-specific DNA binding, was mapped to the central conserved core domain of protein, which is the target for most of the missense mutations inactivating the tumor suppressor function of p53 [59]. It is noteworthy that bacterially expressed, i.e., nonphosphorylated, p53 is virtually devoid of sequence-specific DNA binding activity but exerts exonuclease activity [46], pointing to the possibility that the p53 exonuclease activity might be exerted by hypo- or even nonphosphorylated p53. Treatments activating sequence-specific DNA binding of full-length p53 strongly inhibited its exonuclease activity, indicating that p53 exonuclease and sequence-specific DNA binding are distinct features of the p53 core domain, regulated in opposite manners. Apparently, p53 exerts two complementary functions in maintaining the integrity of the genome. After damage different functional subclasses of p53 will exist within the same cell, then the increase of p53 protein levels not only will activate the potential of p53 to transcribe p53 target genes, leading to growth arrest, but will also increase the amount of p53 with a 3\'→5\' proofreading exonuclease activity. As its basal function in maintaining genetic stability, p53 participates actively in repair processes of endogenous DNA damage and the prevention of mutational events resulting from such damage, through activities not related to sequence-specific DNA binding, specifically through its exonuclease activity [26]. Such p53 then could enhance the accuracy of DNA repair synthesis performed by the error-prone DNA polymerases, e.g. pol α and β. At another level of control, cellular stress activates the functions of p53 generally associated with growth arrest and apoptosis.
Mutant H115N p53, showed markedly reduced exonuclease activity [60]. Surprisingly, purified H115N p53 protein was found to be significantly more potent than wild-type p53 in binding to DNA. Interestingly as well, non-specific DNA binding by the core domain of H115N p53 is superior to that of wild-type p53. Unexpectedly, in contrast to wtp53, H115N p53 was markedly impaired in causing apoptosis when cells were subjected to DNA damage facilitating apoptosis, further supporting the idea that the exonuclease activity and transcriptional activation functions of p53 can be separated. The impact of deficiency of exonuclease activity in p53 is not known. This might be partly due to the observation that tumor derived hot-spot mutants not only fail to function as transcriptional activators but also were reported to be deficient in exonuclease activity. p53 hot spot mutants were categorized into two classes; structural and functional mutants [61]. Since representative members of both classes were defective in exonuclease activity, it is likely that both, structural integrity of the protein and DNA binding activity are essential for each of these two biochemical functions.
p53 activities are extended to normal and cancer cells and they efficiently contribute to genome stability even in the absence of stresses. p53 is expressed constitutively in the cell and is distributed in the nucleus, cytoplasm and mitochondria of unstressed and stressed cells.
The observation that p53 protein is co-located with the DNA replication machinery and may preferentially remove mismatched nucleotides from DNA, suggests a link between p53 and DNA replication fidelity [62]. The localization of p53 in nucleus is essential for its normal function in growth inhibition or induction of apoptosis. The low accuracy of DNA polymerases and imbalance of intracellular dNTP pools are major factors in causing replication errors [3]. The proofreading for such replication errors by the 3´→ 5´ exonuclease activity associated with the DNA replication machinery is extremely important in reduction the occurrence of mutations. DNA polymerase α is lack of proofreading activity and is prone to making replication errors [63]. p53 specifically interacts with DNA polymerase α and has been shown to preferentially excise mismatched nucleotides from DNA and enhance the DNA replication fidelity of DNA polymerase α
It is conceivable that cells lacking p53 exonuclease activity can demonstrate high mutation frequency under stress conditions and the mutations should be reduced by introduction of wild type p53 into the cells. Hydroxyurea (HU), an inhibitor of ribonucleotide reductase involved in the
It was shown that in the early steps of cellular transformation process high incidences of mutations occur, which may be due to misinsertion and proofreading deficiency of DNA polymerases [65]. The existence of complex pol-prim- p53
Notably, the non-genotoxic stress may include a long-lasting, moderate accumulation of p53 in nucleus. In contrast, acute genotoxic stress may induce rapid and transient accumulation of very high levels of p53 with preferential activation of target genes involved in apoptosis. The
p53 is retained in the cytoplasm during part of the normal cell cycle. Wild-type p53 occurs in cytoplasm in a subset of human tumor cells such as breast cancers, colon cancers and neuroblastoma [67-69]. Notably, cytoplasmic sequestration of p53 in tumor cells (that do not have mutated p53), besides structural mutation and the functional inactivation of wtp53, was suggested to be an important mechanism in abolishing p53 function and in tumorigenesis [67,70]. Shuttling between nucleus and cytoplasm not only regulates protein localization, but also often impacts on protein function. Analyses of various cell lines (MCF-7 human breast cancer cells – expressing high levels of wtp53 in nucleus, LCC2-subclone derived from MCF-7 cells-expressing high levels of wtp53 in cytoplasm, MDA cells-expressing high levels of mutant p53 or H1299-p53-null cells), demonstrated that the cytoplasmic extracts of non-stressed LCC2 cells, exert high level of 3´→ 5´ exonuclease activity [55,56]. Interestingly, the 3´→ 5´ exonuclease in the cytoplasmic fraction from LCC2 cells displays identical biochemical functions characteristic for recombinant wtp53 [56]: 1)it removes 3′-terminal nucleotides from various nucleic acid substrates: ssDNA, dsDNA, and RNA/DNA template-primers, 2)it hydrolyzes ssDNA in preference to dsDNA and RNA/DNA template-primers, 3)it shows a marked preference for excision of a mismatched vs correctly paired 3′ terminus with RNA/DNA and DNA/DNA substrates, 4)it exerts the preferential excision of purine-purine (transversion) mispairs over purine-pyrimidine (transition) mispairs, 5)it excises nucleotides from various nucleic acid substrates independently from DNA polymerase, 6) it fulfils the requirements for proofreading function; acts coordinately with the exonuclease-deficient viral (
Interestingly, p53 protein in cytoplasmic extracts of MCF-7 cells displays a relatively high level of 3´→ 5´ exonuclease activity in comparison to nuclear lysates of LCC2 cells [55]. The biochemical difference between the p53 in nuclear and cytoplasmic compartments raises questions whether nuclear p53 loses exonuclease function of cytoplasmic p53 or acquires an additional functions (
Mitochondrial DNA mutations can arise from different sources, including errors made by pol γ, the enzyme that replicates the mitochondrial genome. The mitochondrial pol γ belongs to a family A DNA polymerase, and as observed for other family A DNA polymerases, this enzyme excises the terminal nucleotide at a much slower rate than observed for the potent 3′→5′ exonuclease-proficient T4 DNA polymerase [72]. The mutagenic mechanisms were shown to be replication errors caused by incorporation of wrong nucleotide (as a result of a dNTP excess), or decreased proofreading efficiency. Furthermore, a potentially important source of replication infidelity is damage due to reactive oxygen species. Among several known oxidized dNTPs, one that is particularly common and potentially highly mutagenic is 8-oxo-7,8-dihydro-2\'-deoxyguanosine (8-oxodG) [73]. Incorrect 8-oxo-dGTP-A base pairing can lead to A-T to C-G transversions if the incorporated 8-oxo-dGMP escapes proofreading and any subsequent repair. pol γ, was demonstrated to stably misincorporate 8-oxo-dGTP opposite template adenine in a complete DNA synthesis reaction
A certain fraction of p53 translocates to mitochondria. Mitochondrial localization of p53 was observed in both stressed and non-stressed cells [75,76], where p53 was shown to physically and functionally interact with both, the mtDNA and pol γ in response to mtDNA damage induced by exogenous and endogenous insults [77]. p53 is localized in mitochondria to the inside face of the inner membrane i.e, in matrix, the compartment in which mtDNA is located [57,77]. The functional cooperation of p53 and pol γ during DNA replication was studied using the mitochondrial fraction of p53-null H1299 cells, as the source of pol γ [57]. p53 affected the accuracy of DNA replication by promoting excision of misincorporated nucleotides which increased in the presence of either added recombinant wild-type p53, or endogenous p53 provided by the cytosolic extracts from H1299 cells over-expressing wild-type p53, but not from cells expressing the exonuclease-deficient mutant p53–R175H. Endogenous p53 in mitochondrial extracts of HCT116 (p53+/+) cells had increased exonuclease activity compared with that from HCT116(p53-/-) cells and adding exogenous p53 complemented the HCT116(p53-/-) mitochondrial extract mediated mispair excision. Furthermore, nucleotide misincorporation was reduced in the mitochondrial extracts of HCT116 (p53+/+) cells compared with that of HCT116(p53-/-) cells. Irradiation-induced mitochondrial translocation of endogenous p53 in HCT116(p53+/+) cells correlated with the enhancement of error-correction activities. This evidence strongly supports a direct role of p53 in mitochondria providing exonuclease activity for DNA repair required for error-repair pathway [57]. Therefore, p53 not only serves as guardian of the nuclear genome but also of the mitochondrial genome.
p53 interacts physically with mtDNA and pol γ in response to mtDNA damage induced by endogenous insults including oxidative stress. The intrinsic exonuclease activity of pol γ does not efficiently proofread 8-oxodG misinserted opposite adenine [78]. Once 8-oxo-dGMP is incorporated opposite adenine by pol γ it is preferentially extended rather than excised, which increases its mutagenic potential. Interestingly, human mitochondrial single-stranded DNA binding protein (HmtSSB) was identified as a novel protein-binding partner of p53 in mitochondria. HmtSSB enhances intrinsic 3\'→5\' exonuclease activity of p53, particularly in hydrolysing 8-oxodG present at 3\'-end of DNA, suggesting that p53 is directly involved in DNA repair within mitochondria during oxidative stress.
The accuracy of DNA synthesis reflects complex interactions between the parameters of the catalytic “triad” involved in DNA polymerization: DNA polymerase, the nature of the mispair and proofreading exonucleases (fidelity–enhancing accessory component) [1,22]. DNA polymerase catalyzed both, misinsertion and mismatch extension reactions and the extent of proofreading depend on the type of the mispair, and the influence of surrounding sequences of the template. Various cellular and viral DNA polymerases share common pattern of mispair formation and extension: namely, purine-pyrimidine mispair (
The importance of the mispair extension efficiency as a fidelity parameter was illustrated by the fact that an increased forward polymerization capacity for transition A:C mispair, as compared to transversion A:G mispair, overcomes the ability of p53 exonuclease activity in cytoplasm to excise nucleotide mispairs under the similar exonuclease to polymerase ratios [56]. Indeed, the purine-pyrimidine mispair A:C (the most easily formed and extended) is less efficiently excised and the purine-purine A:A and A:G mispairs (less efficiently formed and extended), are rather efficiently excised. Therefore, it is conceivable that the structural feature that make the mismatched terminus a poor substrate for elongation (polymerization) is a good substrate for degradation (exonucleolysis) [81].
Remarkably, p53 exonuclease displays the same pattern of mispair excision specificity with RNA/DNA substrate observed with DNA/DNA template-primer [50]. The mispair excision pattern obtained with identical RNA and DNA sequences indicates that the p53 exonuclease activity for different mismatches is dependent upon the nature of the mispair. The same relative order obtained during replication in extracts and in reconstituted reaction, demonstrates the reproducibility of the observations, thus indicating that this specificity reflects the proofreading potential of human replication apparatus.
Among the base substitution mutations, 80% are transitions and 20% are transversions [13]. An interesting observation is that external proofreading activity in the replication apparatus may preferentially correct some of the misincorporated beses to reduce the rates of transversions. p53 may affect the mutation spectra of DNA polymerase (
The mutational spectra and error rates during DNA synthesis probably depends on the composition and position of mispair, since each position provides a new set of protein-DNA contacts. There is the possibility that neighboring nucleotide sequence may influence recognition of the altered geometry of the mismatch by the enzyme/protein responsible for the proofreading or/and proofreading efficiency. The fact that p53 binds mismatch in the two different sequence contexts tested, indicates that the recognition and binding of 3\'-terminally mismatched DNA substrates by p53 might be independent of the sequence context. Since formation of exonuclease complexes requires “melting” of the terminal three base pairs at the primer end, the nature of mismatch at the primer end and the A+T- or G+C-richness of the primer terminus affect the rate for formation of exonuclease complexes. It has been proposed that high A-T content of the primer terminus compared with high G-C content increases excision rates by assisting the strand separation process. Hence, a comprehensive study of various DNA substrates are needed to determine the effect of local sequence context on the substrate specificity of the p53 exonuclease and whether p53 could take advantage of A+T richness to prepare duplex DNA for the hydrolysis reaction.
Following the incorporation of wrong nucleotide the DNA polymerase stalling and the kinetic delay allows error correction by intramolecular or/and intermolecular pathway [3]. The intramolecular pathway entails “movement” of the primer end from the polymerase to the intrinsic exonuclease active site (without dissociating from the DNA). In this way, DNA polymerase functions as a “self-correcting” enzyme that removes its own polymerization errors as it moves along the DNA. The intermolecular proofreading may occur when misinsertion is followed by polymerase dissociation from the mismatched template-primer, leaving the 3′ terminal mispair accessible to the external exonuclease for binding and error correction. In both cases, the efficiency of editing misinserted nucleotides by a 3´→ 5´ exonuclease would be directly dependent on the DNA polymerase capacity to extend from a misincorporated nucleotide.
Polymerase dissociation at a mispair is an important consideration for proofreading for both exonuclease-deficient and exonuclease-proficient polymerases, thus allowing error correction by a separate 3´→ 5´ exonuclease. The formation of exonuclease complex with the primer end of the mismatched DNA participates in error correction during DNA synthesis [42]. A functional interaction between the p53 exonuclease and DNA polymerase activities was observed. The 3\'-terminal mismatched DNA binding and exonuclease activities of p53 are implicated in the recognition and excision step of mismatch repair. It is conceivable that the binding of p53 to mismatched DNA and preferential excision of mismatched nucleotides may be a relevant event in the biological function of the protein in DNA repair. The experiments in which DNA polymerases, either exonuclease-deficient (
It is important to note, that DNA polymerase could gain enormous benefit from proofreading even from a relatively weak exonuclease, if the polymerase has difficulty extending from a particular mispair [20]. Exonuclease has a dramatic impact on the accuracy of polymerase by preventing the occurrence of base substitutions during continues DNA replication. All that is required is discrimination against extension from a mispair within the polymerase active site.
Model for error-correction by p53. The incorporation of wrong nucleotide ( ) into DNA results in DNA polymerase (pol) dissociation from the template-primer, leaving the 3\'-terminal mispair accessible to the p53. Upon excision of the mispair, the p53 dissociates thus allowing the DNA polymerase to re-associate with the correct 3\'-terminus and resume DNA synthesis.
Two variables might affect the efficiency of excision from the mispair [1]. First, one hallmark of proofreading is the “next-nucleotide effect”. Increased proofreading at the expense of DNA replication is observed at low concentrations of dNTPs, a condition which prevents error production during replication
Second, the polymerase/exonuclease ratio serves as an important enzymatic “marker’ of polymerase fidelity [1]. Exonucleolytic proofreading is a major determinant of replication fidelity. The balance between the DNA polymerizing and 3´→ 5´ exonuclease reactions usually affects the overall accuracy of DNA synthesis to ensure optimal DNA replication efficiency and to prevent excessive DNA degradation of correctly synthesized DNA. The high ratio of exonuclease to polymerase at the constant dNTP concentrations may increase the fidelity of DNA synthesis.
Cellular responses to DNA damage include repair processes that act coordinately prior to, during and after DNA replication, to maintain genomic stability. The accuracy of DNA synthesis might respond to alterations in composition of replication complex. p53 function may be regulated by controlling where the protein is in the cell. Various stress conditions may trigger distinct signaling pathways in controlling p53 nucleo–cytoplasmic-mitochondrial translocation, thus contributing to heterogeneity of p53-dependent responses. The identification of the p53 protein in cytoplasm or in mitochondria that may enhance the fidelity of DNA polymerase suggests that the accuracy of DNA synthesis by the enzyme may respond to alterations in composition of replication complex. Most probably, p53 in nucleus or cytoplasm or mitochondria might have a transient interaction with replication complex. Therefore, the DNA synthesis in each compartment may be dynamic process with p53 component binding and dissociating the DNA polymerization complex during dsDNA synthesis, thus affecting the polymerase/exonuclease (p53) ratio. The change in the ratio of DNA polymerase vs exonuclease (p53) could be achieved through a reduction in polymerization efficiency of DNA polymerase due to mutations, or from over-expression of p53, or through p53 gene induction (increase in p53 concentration) or p53 targeting (increase in local nuclear or cytoplasmic or mitochondrial concentration). p53 is able to excise 3\'-terminal nucleotides during the ongoing DNA synthesis
Many nucleoside analogs (NAs), potent anti-cancer and antiviral drug compounds, include a variety of purine and pyrimidine nucleoside derivatives which may compete with physiological nucleosides. Nucleoside analogs, clinically active in cancer chemotherapy (
Proofreading exonuclease activity is capable of removing wrong nucleotides from DNA, providing a mechanism that potentially causes drug resistance. In general, the amount of NAs presented at the DNA termini depends on the efficiency of the incorporation of the compounds by DNA polymerases and on the rate of excision by 3´→5´ exonucleases [83]. The excision of the incorporated NA from the 3’-end of DNA by exonucleases may decrease their potential for chain termination and may be viewed as a potential cellular mechanism of resistance to anti-viral drugs or anti-cancer NAs. The role of p53 exonuclease in maintaining genomic stability in mammalian cells is particularly relevant with respect to the development of anticancer and antiviral therapies.
Many anticancer agents induce cellular cytotoxicity by causing DNA damage. Cells developed several repair mechanisms to facilitate the excision of incorporated NAs. The cytotoxic activity of gemcitabine (2\'2\'-difluorodeoxycitidine, dFdC) was strongly correlated with the amount of dFdCMP incorporated into cellular DNA. Interestingly, dFdCTP incorporation by human DNA polymerase α results in “masked termination” of DNA synthesis, where following a single dFdCTP incorporation into DNA, the primer is extended by only one additional dNTP before polymerization is inhibited [84]. The p53 protein recognizes dFdCMP-DNA in whole cells, as evidenced by the fact that p53 protein rapidly accumulated in the nuclei of the gemcitabine treated ML-1 cells [85]. Although, the excision of the dFdCMP at the penultimate position from the 3’-end of the DNA was slower than the excision of matched or mismatched nucleotides in whole cells with wtp53 (ML-1) and not detectable in CEM cells harboring mutant p53. ML-1 cells were more sensitive to the cytotoxic effect of the drugs compared to the p53-null or mutant cells. Transfection of p53-null cells with wild-type p53 expression vector enhanced the sensitivity of the cells to gemcitabine. Taken together, these authors concluded that recognition of the incorporated NAs in DNA by wild-type p53 did not confer resistance to gemcitabine, but may have facilitated the apoptotic cell death process. It was reported that treatment with gemcitabine resulted in an increased production of DNA-dependent protein kinase (DNA-PK) and p53 complex in nucleus, that interacts with the gemcitabine-containing DNA [86]. DNA-PK and p53 sensor complex may serve as a mechanism to activate the pro-apoptosis function of p53. Apparently, the prolonged existence of the NA-stalled DNA end induced the kinase activity, which subsequently phosphorylated p53 and activated the downstream pathways leading to apoptosis.
Remarkably, p53 present in complex with DNA-PK exhibited 3′→5′ exonuclease activity with mismatched DNA, however the active p53 was unable of excising efficiently the incorporated drug from NA-DNA construct containing gemcitabine at the penultimate site and a matched pair at the 3’-end [86]. It should be noted, that the specific effects of gemcitabine exposure appeared to vary depending on the duration of treatment and upon the cell line. The drug-induced apoptosis were further compared in two lines derived from the MCF-7 cells: MN-1 cells with wild-type p53 and MDD2 cells containing mutant p53 [87]. The MDD2 cells were significantly more resistant to gemcitabine induced cytotoxicity than the MN-1 cells. Unexpectedly, MDD2 cells accumulated more gemcitabine than MN-1 cells, with higher incorporation into nucleic acids. The activation of gemcitabine to its phosphorylated form was similar in both cell lines and it was suggested that the absence of 3´→5´ exonuclease activity in the mutant p53 cell line accounted for the enhanced incorporation into nucleic acids. The presence of a dysfunctional p53, presumably, allows the cells that accumulate DNA damage to continue proliferating. It should be pointed out, that wild-type p53 in ML-1 cells removed the purine nucleoside analog fludarabine (F-ara-A) more efficiently than gemcitabine [85]. Further studies are needed to assess the role of p53 in cellular response to various anti-cancer purine and pyrimidine NA-induced DNA damage.
HIV-1 RT readily utilizes many NAs and the incorporation of nucleoside RT inhibitors (NRTIs) into the 3’-end of viral DNA leads to chain termination of viral DNA synthesis in cytoplasm [88]. The ability of p53 exonuclease activity to excise NA from DNA was studied. A decrease in incorporation of the NA (
Acquired mitochondrial toxicity occurs as a consequence of incorporation of anti-cancer or anti-viral NA into mtDNA and/or inhibition of mtDNA replication [90,91]. NRTIs, in addition to the target viral polymerase in cytoplasm (antiviral activity), can be incorporated into a mtDNA by pol γ, leading to termination of mtDNA synthesis and mitochondrial dysfunction (host toxicity). Mitochondrial toxicity may be caused by termination of the growing nascent DNA strand after incorporation of the NRTIs into mtDNA or by inhibition of pol γ exonucleolytic proofreading [90,91]. DNA synthesis/repair proceeding in nucleus-free mitochondria, relies upon a preassembled DNA replication machinery of pol γ and multiple proteins to maintain mtDNA integrity. p53 in mitochondria may functionally interact with pol γ, thus providing a proofreading function during mtDNA replication for excision of NAs [92]. Indeed, increased excision of the incorporated NAs from DNA was detected with H1299mit in the presence of recombinant or endogenous wild-type p53 but not exonuclease-deficient mutant p53-R175H: Mitochondrion-localized elevation of p53 following the IR-stress stimuli correlates with the low incorporation of NA. The fact that p53 localizes to the mitochondria and interacts with mtDNA and pol γ, taken together with observations that the presence of p53 (provided by recombinant or endogenous p53) reduces the amount of incorporation of NA in H1299mit, suggests that p53 may potentially participate in NA excision. p53 in mitochondria probably have a transient interaction with replication complex; the DNA synthesis may be dynamic process with p53 component binding and dissociating the polymerization complex during DNA synthesis, thus affecting the polymerase (pol γ)/exonuclease(p53) ratio. Consequently, the decrease in the ratio of pol γ/p53 due to the increase in local p53 concentration in mitochondria, may enhance the proofreading efficiency and excision of NA by external p53. Knowledge of the mechanism of inhibition of pol γ may be utilized to obtain selectivity for HIV-1 RT over pol γ. The removal of the incorporated NRTI by p53 exonuclease, indicates that the presence of the cellular component-p53 in mitochondria may be important in defining the cytotoxicity of NRTIs toward mitochondrial replication, thus affecting risk-benefit approach (NRTI toxicity versus viral inhibition).
Although dFdC is not a chain terminator, the extension of a dFdCMP-terminated primer is 25-fold slower than the extension of a canonical DNA primer in mitochondria. Moreover, the primer 3′-dFdCMP was excised with a 50-fold slower rate than the matched 3′-dCMP. Given that mtDNA repair is limited and inefficient [93], persistence of dFdCMP within mtDNA is predicted to be likely. The toxicological profile of gemcitabine resembles that of many other anti-viral nucleoside analogs and frequently mimics the symptoms of heritable mitochondrial defects. The mitochondria may be able to remove chain-terminating nucleoside analogs and resume normal mtDNA replication, but nucleoside analogs that do not chain terminate, and therefore can become part of the mitochondrial genome, may exert long term toxicity [85]. pol γ was able to extend a DNA primer containing 3′-dFdCMP although with decreased nucleotide incorporation efficiency at the first two downstream positions. p53 is able to remove the incorporated anti-cancer drug arabinosylcytosine (Ara-C) (pyrimidine analog) from DNA incorporated by pol γ in mitochondrial fraction of p53-null cells [92]. The binding and removal of chemically active anti-cancer and anti-viral NAs from DNA by p53 may lead to either drug resistance or activation of p53 pro-apoptotic functions (Fig.3).
The potential functions of p53 in response to nucleoside analog-induced DNA damage. The p53 protein, following the recognition and preferential binding to the drug-containing DNA could display two different functions: the removal of the incorporated NA from DNA, thus conferring the resistance to the drugs, or may serve as a mechanism to activate the pro-apoptosis function of p53 and trigger the cell death program.
p53 is a multifunctional protein with positive and negative effects. In general, drug resistance that occurs in cancer chemotherapy and antiviral therapy is a negative event that will decrease the efficacy of the treatment. The behavior of p53 exonuclease probably depends on the sub-cellular localization of the p53, local concentration, nature of NA (purine, pyrimidine), position of the NA (3’-terminal NA, analog residue at the penultimate position and nature of the subsequent correct nucleotide) and on the local DNA sequence composition. The recognition and removal of NA from drug-containing DNAs by p53 exonuclease activity in various compartments of the cell may play a role in decreasing drug activity, leading to various biological outcomes: 1)the excision of the incorporated NA from DNA in nucleus may confer resistance to the drugs (negative effect) [85]; 2)the removal of the NA by p53 from DNA incorporated by HIV-1 RT in cytoplasm may confer resistance to the drugs by non-viral mechanism (negative effect) [89] and 3)the excision of NAs from mitochondrial DNA may decrease the potential for chain termination and host toxicity (positive effect) [92]. Apparently, the presence of p53 in mitochondria may be important, since the excision of the mispair and NA by p53 is favorite event for mitochondrial function.
Nature has devised multiple strategies to safeguard the genetic information and developed intricate repair mechanisms and pathways to reverse an array of different DNA lesions, including mismatches. An accessory proofreading exonuclease would be critical for the removal of the mispairs and therefore, for the maintenance of genomic integrity. The high incidence of mutations may be due to misinsertion and proofreading deficiency of DNA polymerases [65]. Mammalian cells have evolved several repair mechanisms for the maintenance of genomic integrity to prevent the fixation of genetic damage induced by endogenous and exogenous mutagens [3]. Cells may have several 3‘→5’ exonucleases to preserve genomic integrity during DNA synthesis. Under conditions where the activity of one exonuclease is inactivated, the function of another exonuclease might be important for correcting errors produced during DNA replication. p53 was shown to be an example of accessory protein that may enhance the fidelity of DNA synthesis by exonuclease-deficient DNA polymerase,
p53 plays a pivotal role in the regulation of cell fate determination in response to a variety of cellular stresses. p53 may exert the functional heterogeneity in its non-induced and in its activated state. Furthermore, p53 is able to elicit a spectrum of different biological effective pathways in nucleus, cytoplasm and mitochondria. The increase of p53 protein levels will increases the amount of p53 with a 3´→5´ exonuclease activity. Hence, it is of interest to elucidate 3´→ 5´ exonuclease activity nucleus, cytoplasm and mitochondria of the cells with activated p53 induced by drug treatments (in the absence of DNA damage) or following UV irradiation (in the presence of DNA damage).
The role of p53 is particularly relevant with respect to the development of anticancer and antiviral therapies. The potency of NAs is dependent upon their incorporation at the 3’ ends of replicating DNA. However, clinical drug resistance limits the efficacy of these compounds. Cells have evolved several repair mechanisms to facilitate the excision of misincorporated nucleotides or nucleoside analogs. Uncovering the mechanisms, which are responsible for DNA repair of NA-induced DNA damage will have therapeutic value. The stress induced activation of p53 that occurs during cancer chemotherapy has negative and positive effects. The p53 protein is able to remove incorporated NA. Therapeutic strategies based on p53 are particularly interesting because they exploit the cancer cell’s intrinsic genome instability and predisposition to cell death-apoptosis. p53 may remove incorporated therapeutic NAs from DNA or trigger apoptosis. The knowledge regarding functions of p53 in genome integrity and cancer evolution may facilitate drug screening and better design of therapeutic approaches.
The functional interaction between p53 and DNA polymerase may have important consequences for the maintenance of genomic integrity and pose significant challenges to the development of p53-targeting cancer therapies. Mutant p53 can be classified as a loss-of-function or gain-of-function protein depending on the type of mutation [27,28]. Characterization of exonuclease-deficient H115N mutant p53 revealed that although exonuclease-mutant H115N p53 can induce cell cycle arrest more efficiently than wild-type p53, its ability to produce apoptosis in DNA damaged cells is markedly impaired [60]. Does exonuclease-mutant p53 promote mismatch genetic instabilities? What is the ultimate phenotypic result of this genomic instability? Is it truly contributing to the increased proliferation, seen in tumors of mutp53 mice, and can these results be extended to human tumors? In order to answer these questions, more studies must be conducted on the biology of various mutant p53\'s and their interaction with the factors involved in DNA repair and apoptosis. Characterizing the instability phenotype of cells after perturbing these interactions will lead to a better understanding of the main causes of mutant p53-mediated genomic instabilities, which might also be point mutant-specific. p53 have a dual role in response to therapy, as exonuclease that by excision of incorporated anti-cancer drugs may confer resistance to drugs or as mediator of cell death induced by chemotherapy [85]. These features could serve as a template for the development of p53-targeting cancer therapies.
A major focus in the future would be to characterize the cellular and biological functions of p53 in mitochondria in response to various stresses. There are many missing points about the biological roles of p53 in mitochondria that still remain to be identified. How p53 can be imported into mitochondria? Whether p53 determines the percent of mutated mtDNA (heteroplasmy in a cell)? Uncovering the mechanisms by which pol γ-mediated mtDNA mutations and depletion are manifested in tissues in the absence and presence of p53 is the next step in understanding causes for mtDNA –related diseases. Understanding how p53 can be imported into mitochondria, will be important and could contribute towards the design of new therapies for cancer and other diseases.
The control of the viral mutation rate could be a viable anti-retroviral strategy. Still more work needs to be done in order to understand the molecular mechanisms involved in controlling fidelity not only at a molecular level (
Depletion and mutation of mitochondrial DNA during chronic NRTI therapy may lead to cellular respiratory dysfunction and release of reactive oxidative species, resulting in cellular damage [91]. Future NRTIs should provide higher specificity for HIV-RT and lower incorporation by pol γ to minimize mitochondrial toxicity. Whether the effective targeting of p53 in mitochondria may result in decrease of mitochondrial toxicity in response to conventional anti-viral therapies? Further studies are needed to elucidate if p53, by error-correction functions in mitochondria, can decrease mitochondrial toxicity.
Frostbite is defined as injury to body tissues caused by exposure to extreme cold, typically affecting the extremities and often involving only the skin, which initially becomes white and hard, but in severe cases resulting in gangrene of deeper tissues and loss of the affected parts [1].
The first physical evidence of frostbite injury dates back to 5000-year-old pre-Columbian mummy discovered in the Andes [2]. Baron Dominique Larrey, Napoleon’s surgeon-in-chief during the infamous 1812 to 1813 retreat from Moscow, gave the first description of pathophysiology and management of frostbite [3]. Heavy bombers crew during World War II sustained more injuries due to high altitude frostbite than from all other causes combined [4]. Nazi-German Waffen during WWII had more than 10 mountain division of troops well-trained and adapted to operate cold of Arctic and mountains. Many of those mountain troops experienced devastating cold injuries [5].
Thus, the frostbite is a significant cause of long term irreversible morbidity in military medicine. Despite this, frostbite management has remained constant and unchanged. One of the most important factor often ignored is hypoxia related injuries associated with frost bite. The soldiers are often deployed at high altitude, face harsh climatic conditions in terms of exposure to cold and hypobaric hypoxia. Collectively, both these factors usually alter the course of certain conditions like cold related injuries at this height. However a number of novel therapies have been introduced in the last two decades which have led to promising, tissue-saving, outcomes.
The aim of this chapter is basic understanding of frostbite at high altitude conditions and incorporating latest frostbite management strategies to existing ones, both at prehospital levels and hospital levels, in order to maximise the tissue salvage of the patients.
Frostbite continues to afflict modern militaries [6, 7, 8]. Within the civilian, most common is mountaineers.
The predisposing factors to cold injury include high altitude (above 17,000 feet), alcohol consumption, psychiatric illness, smoking, immobility, homelessness, unplanned exposure to cold with inadequate protection, contact with cold objects, previous history of cold injury, medical conditions like atherosclerosis, medications (eg, b-blockers), and working with equipment that uses refrigerant liquids and gases [9, 10, 11, 12, 13, 14]. Also genetic factors like African American ethnicity, O group blood typing and angiotensin-converting enzyme DD allele may increase risk to cold injuries [7, 15, 16].
30–49 years are the Most susceptible age groups [17, 18]. Most common anatomic sites involved are hands and feets (90% of all recorded sites), others include ears, nose, cheeks and penis [17, 18, 19, 20, 21, 22].
Two mechanisms that are apparently responsible for cold injury include direct cellular injury and progressive dermal ischemia.
Due to freezing of tissue there is extracellular ice crystal formation, leading to electrolyte disturbances, intracellular dehydration and shrinkage leading to cell injury and death [23]. As temperature further falls, there is intracellular ice crystal formation, which expands leading to mechanical destruction of cells [24].
The body responds initially to it by alternating cycles of vasoconstriction and vasodilatation, known as “the hunting reaction” [25]. When vasodilatation occurs, there is reestablishment of blood flow, which is called thawing. The repeated freeze/thaw cycle causes most damage, and further leads to progressive thrombotic phase [24, 26, 27].
Progressive dermal ischemia is more severe than the direct cellular damage [28, 29]. Figure 1 describes the events in progressive dermal ischemia [22].
Pathology of progressive dermal ischemia in frost bite. TXA2, thromboxane A2; PGF2α, prostaglandin F2α; CAM, cellular adhesions molecules; MMPs, matrix metalloproteinases; ROS, reactive oxygen species.
Various studies have shown similarities in the progressive dermal ischemia due to frostbite and thermal burns [30, 31]. Blebs or blisters may develop secondary to vasodilatation, oedema, stasis and coagulation. Platelet and erythrocyte aggregates leads to thrombosis of the vessels in viable tissue. Local inflammatory response and associated injuries may cause increased compartment pressures [32]. Robson and Heggers found markedly elevated levels of prostaglandin F2a and thromboxane B2 (a stable metabolite of thromboxane A2) in frostbite blister fluid [30, 33, 34]. Raine et al. demonstrated that prostaglandin and thromboxane inhibitors resulted in significantly improved tissue survival in rabbit ear frostbite [35]. Prostaglandin F2a (PGF2a) and thromboxane A2 (TXA2) cause platelet aggregation and thrombosis which results in ischaemia [32]. Thus there is significant role of the metabolites of arachidonic acid pathway as mediators of progressive dermal ischemia in burn and frostbite.
Other studies indicate the cell mediated inflammatory response which leads to progressive ischemia and tissue necrosis is similar to the response seen following ischemic/reperfusion injury [36]. The ischemic/reperfusion injury has been described as the paradoxical exacerbation of cellular dysfunction and death, following restoration of blood flow to previous ischaemic tissues [37]. During reperfusion, an inflammatory reaction occurs with neutrophilic aggregation and adhesion to endothelial cells leading to the production of free radicals [38]. Manson,
Thrombosis, endothelial damage, intravascular sludging, inflammatory mediators, free radicals, neutrophil adhesion, platelet aggregation, reperfusion injury, and oedema all play a role in contributing to progressive dermal ischemia and leads to cell death [22, 30, 35, 36, 39, 40].
Frostbite is more common at high altitude than at sea level. As the altitude increases the maximum oxygen uptake falls thereby reducing the body’s ability to produce heat, while dehydration, cold, the fall in plasma volume which occurs at high altitude and increased erythropoietin production all work to increase blood viscosity and reduce peripheral blood flow. This reduced peripheral perfusion due to hypoxia causes additive effect in pathophysiology of frostbite. A reduction in calorie intake also reduces insulating subcutaneous fat [39, 41]. Also, the blood microcirculation recovery after high altitude frostbite is significantly slower than the normal frostbite [42].
Historically, the degrees classification has been favoured. It classifies frostbite into frostnip, first-degree, second-degree, third-degree, and fourth-degree frostbite depending on depth of injury [22]. This classifications fail to predict the extent of likely amputation levels and aid little in initial management.
Cauchy and colleagues [43] proposed a classification system for severity of frostbite cases, as depicted in Table 1 (Figure 2). The advantage of this classification is that it gives an early prognostic indicator of bone and tissue loss and the likely anatomic level of loss. This grading system relies on isotope bone scanning. In the field, Cauchy and colleagues [44] suggest the use of portable Doppler or the clinical stigmata of soft tissue cyanosis as surrogate markers for amputation risk.
Grade | Extent of initial lesion day 0 | Bone scan, day 2 | Blisters at day 2 | Prognosis at day 2 |
---|---|---|---|---|
1 | No lesion | Unnecessary | No blisters | No amputation |
2 | Lesion distal phalanx only | Reduced radiotracer uptake | Clear blister fluid | Tissue excision |
3 | Lesion distal, inter-and proximal phalanx | No radiotracer uptake on digit | Hemorrhagic blister fluid | Bone amputation of digit |
4 | Lesion in carpel/tarsal | No tracer uptake in carpal/ tarsal | Hemorrhagic blisters carpal/ tarsal | Bone amputation of limb |
Classification scheme for severity of frostbite injuries.
After Cauchy et al. [43].
The initial assessment on arrival in hospital, day 0, is made after rapid rewarming.
Grades of frostbite.
Initial symptoms include numbness and pale/bluish discolouration in the affected part. Following thawing, patient may complaint of throbbing pain and tingling sensation with/ without appearance of blisters (clear/hemorrhagic) in affected part. Long term sequelae includes cold insensitivity, sensory loss, hyperhidrosis [22], growth plate disturbances [25, 45], osteoarthritis [46], chronic pain [25], and hypertrophic calcification [47]. There are few case reports of frostbite with extensive limb involvement showing rare presentation as acute compartment syndrome and increasing rhabdomyolysis. There was no other clear aetiology of rhabdomyolysis in these cases and they required compartment release [48].
On physical examination favourable prognostic indicators include normal skin colour, sensation to pinprick, blisters with clear fluid and the ability of the skin to deform under direct pressure. Poor prognostic indicators include non blanching cyanosis, hemorrhagic blisters and hard, non deforming skin [22].
Chilblains is a self limiting, mild form of cold injury in which there is appearance of red, itchy lesions on the limbs on exposure to temperature above freezing point. Tissue loss is rare. It is managed conservatively by limb elevation and application of moisturising lotions [22].
In order to provide early assessment of tissue viability and management several radiological techniques can be used like bone scanning, magnetic resonance angiography (MRA), and angiography.
Technecium 99 (99 Tc) triple-phase bone scanning has become the standard imaging study when used at day 2 post cold injury [43, 49, 50, 51]. It helps to assess tissue viability but fails to show clear-cut soft tissue demarcation. However, MRA is often easier to access and allows direct visualisation of thrombosed vessels and may show a clearer demarcation of viable and ischemic tissues. Therefore some authors advocate MRA as superior technique [52, 53]. Digital subtraction angiography can be performed on individuals who are being considered for thrombolysis. It visualises vessel patency but do not sufficiently clarifies the level of viability [49, 54].
As “prevention is better than cure” it is the responsibility of commanders, team leaders, individuals, and companies/employers who place individuals in at-risk areas. The following preventive measures should be adopted: 1) maintain adequate hydration and nutritional status; 2) use multilayered clothing preferably wool or synthetics such as polypropylene as these materials insulate even when wet. Also avoid constricting items like tight cramp on straps. Proper fitting boots should be worn. Mittens are preferable to finger gloves; 3) avoid sweating and prolonged immobility; 4) Avoid fatigue and one should not climb in adverse weather conditions; 5) buddy care system should be followed and one should daily inspect foot to look for any signs of cold injury; 6) ensure beneficial behavioural responses to changing climatic conditions like avoiding alcohol and smoking. Alcohol causes cutaneous vasodilatation which gives temporary warmth but actually causes greater heat loss. Similarly, nicotine in cigarette causes vasoconstriction and thereby aggravates cellular hypoxia [55]; 7) do not touch metallic objects in extreme cold or in moderate cold if wet; 8) leaders/commanders must ensure that all are fit, trained, and capable of operating in proposed location/climate; this should take into account the co-morbidities and current medications; and 9) a thorough evacuation and medical plan must be in place before departure; this must include communications.
Before evaluating the patient one should consider that once the boots are removed, the swelling may occur, so prevent redonning of boots. Also, freeze–thaw–freeze cycles must be avoided; therefore, only consider rewarming if this can be avoided. It may be better to walk out on a frozen foot.
It is treatment by persons with limited medical background.
One should thoroughly assess the patient as he may be having concurrent hypothermia. Remove all wet clothing and jewellery. Provide general warmth. Rehydrate the individual with adequate warm fluids. Avoid smoking and alcohol.
Immerse the affected part in water at 40 °C to 42 °C with a mild antibacterial agent like providone-iodine [25, 35, 54, 56]. If a thermometer is not available then first the unaffected limb should be placed in water for at least 30 seconds to ensure that the water is not too hot as the affected limb will have impaired temperature sensation. Twice-daily baths are recommended and redressing should be done every 12 to 24 hours [57]. Avoid mechanical trauma to the affected part. Do not rub or applying dry heat (heat pads) to frozen tissue. Thawing is complete only when the red/purple and pliable texture of affected part is achieved [25, 58]. Once thawing is complete, the limb should be allowed to air dry. Thereafter keep affected limb completely warm. Avoid re-exposure. Elevate the affected limb to reduce oedema [57].
Cold-injured part is a tetanus prone wound; therefore follow standard tetanus toxoid guidelines [23, 25, 59]. Give ibuprofen 12 mg/kg twice a day up to a maximum of 2400 mg/d, for analgesia and to reduce inflammation (unless contraindicated) [49]. It supersedes aspirin as aspirin inhibits prostaglandins, some of which are beneficial to healing [23, 24, 25].
Portable recompression bag simulate physiological “descent” and there is increase in SpO2 [44, 61]. It can be used as an adjunct, provided patient is fully conscious and it should not delay evacuation. Supplemental oxygen may be beneficial at high altitudes posts [44] with an aim to maintain SpO2 greater than 90% [57].
Once the patient is transferred to a hospital take detailed history including onset of injury (<24 hours or > 24 hours ago), mechanism of injury, climatic conditions at time of injury, any freeze–thaw–freeze events, and in-field treatment. Reassess the patient and affected parts thoroughly. Keep the individual in a warm room. Remove all jewellery if not removed previously. Rehydrate the patient with warm fluids and give high-protein, high-calorie diets [62]. Follow rewarming principles as described above.
Give tetanus toxoid, if not given previously. Continue oral ibuprofen and oxypentifylline as described above. Analgesics may be required on an individual basis (paracetamol, tramadol, opiates). The role of prophylactic antibiotics in frostbite is controversial [17]. However, systemic antibiotics must be commenced in proven infection as guided by skin swab culture sensitivity [63].
Blisters give an indication to the depth of injury. White/clear blisters indicate superficial injury and contains high levels of prostaglandin F2α and thromboxane A2 [30]; therefore aspiration may be beneficial. However, few authors have advocated that clear blisters should be left intact, and de-roofing may result in increased susceptibility to opportunistic infections [64]. Hemorrhagic blisters indicate structural damage to reticular dermis; many authors advocate them to be left intact due to risk of desiccation [18, 24]. The Wilderness Medical Society guidelines advise drainage of white/clear blisters and to leave hemorrhagic blisters alone [57].
Dressing of the affected areas should be done 12 or 24 hourly and the affected part should be splinted and elevated. Dressing should be non constrictive and loose with padding between the digits. Apply
Take photograph of the affected part on admission and subsequently every alternate day. If facilities are available one should consider imaging like bone scanning, magnetic resonance angiography (MRA), and angiography. It offers prognostic information and guide management.
The following adjunctive therapies have been described recently.
It is a grade 2C recommendation for use when thrombolytics or iloprost are not going to be used. However, there are no clinical trials to prove its role and also it can cause anaphylaxis; [44] We do not recommend it.
Post thawing, thrombosis is seen to occur in superficial dermal plexus. Therefore anticoagulation with heparin may have a role in frostbite but there is no evidence in literature for it [22, 56, 65]. So it is not recommended as monotherapy.
Hyperbaric oxygen therapy (HBOT) increases oxygen delivery to the tissues provided there must be a patent vasculature [57]. However, it could help during rewarming phase and at high altitude (usually >4000 meters) when SpO2 is less than 90% [66]. It is suggested that immediately after rapid rewarming, do HBOT for 1 hour. Thereafter, it can be repeated every 3 hours during the first 12 hours while the patient is awaiting evacuation [44, 61].
Many studies have shown that sympathetic nerve block in upper limb causes vasodilation, raised skin temperature and pain relief [67]. Its role in frost bite cases is mixed [68, 69, 70, 71]. However, it is possible that very early intervention with sympathetic blockade in the field may be more effective. Chandral et al. described a technique for giving peripheral nerve block [69]. The same technique was used by Pasquier et al. in field area for managing grade 2 frostbite in bilateral hand [72]. He performed bilateral wrist block using 0.5% ropivacaine. There was good recovery without amputation. Taylor et al. used continuous epidural anaesthesia for managing frostbite cases of lower limbs [73]. Therefore, for grade 2–4 frostbite cases following thawing, which are limited to hands, distal volar forearm nerve block may be considered. Similarly for lower limbs, continuous epidural catheter may be considered for analgesia and vasodilation.
Thrombolytic agents have been used for reversing microvascular thrombosis and restoring blood flow. Thrombolysis using streptokinase, urokinase or recombinant tissue plasminogen activator (rTPA) has resulted in reduced amputation rates [14, 49, 74, 75]. Limited data suggest that rTPA in frostbite is most effective when used within 6 to 24 hours of rewarming [14, 44, 49, 74, 76]. However, studies have shown that ilioprost (a synthetic analogue of prostacyclin PGI2) has better safety profile than rTPA and is most effective up to 48 hours after rewarming [77, 78]. In field location, grade 2 to 4 frostbite may result in tissue loss if not treated. Therefore, trained medicine specialist can initiate treatment with ilioprost or rTPA, considering their contraindications and complications, for grade 2 to 4 frostbite as per dosage and considerations given in Tables 2 and 3 respectively [44].
Administration and monitoring | Dilute 1 vial 0.5 mL iloprost in 24.5 mL NaCl 9% Syringe pump: 25 mL - speed: 1 mL/ h for 30 minutes, then 2 mL/h for 30 minutes, then 3 mL/h for 30 minutes, then 4 mL/h for weight < 75 kg or 5 mL/h for weight > 75 kg Continue until 25 mL is delivered; all patients receive 1 vial Monitor HR and BP every 30 minutes |
Complications and their management | In case of side effects decrease to previous lower step If systolic BP <90 mmHg decrease to lower step |
Contraindications | Hypotension, hypersensitivity, pulmonary edema, cardiac arrhythmia, active ulcer disease, major trauma; unknown effects on pregnancy |
Precautions | Anticipate nausea and vomiting, pain and hypotension; keep patient supine |
Protocol for intravenous prostacyclin.
HR, heart rate; BP, blood pressure.
Administration | Weight < 67 kg: 15 mg IV bolus, then 0.75 mg/kg over 30 minutes, then 0.35 mg/kg over next 60 minutes |
Ideally given with a portable syringe pump | Weight > 67 kg: 15 mg IV bolus, then 50 mg over 30 minutes, then 35 mg over next 60 minutes. Total not to exceed 100 mg Heparin after bolus |
Contraindications | Recent trauma, bleeding diathesis, stroke within 3 months, on anticoagulants, hypersensitivity; BP >180 mmHg systolic or 110 mmHg diastolic |
Precautions | High altitude: HAPE or HACE, retinal haemorrhage, gastritis |
Complications and their management | Bleeding: stop infusion, haemostasis if possible, consider tranexamic acid Angioedema: stop infusion, antihistamine, corticosteroids |
Protocol for intravenous rTPA.
rTPA, recombinant tissue plasminogen activator; IV, intravenous; BP, blood pressure; HAPE: high altitude pulmonary edema; HACE: high altitude cerebral edema.
Botulinum toxin is produced by
In addition it causes reduction in pain by blocking recruitment of specific α2- adrenoreceptors, which decreases the activity of chronically upregulated C-fibre nociceptors [81]. Also the effects last for 3–4 months. Norheim et al. used BTX-A injections at the neurovascular bundles in the palm of each hand at the level of the metacarpophalangeal joints in a patient with frostbite sequelae [82]. Their study shows that BTX-A has positive effects on skin perfusion, cold hypersensitivity and pain. They speculated that early treatment of frostbite sequelae with BTX-A may be advantageous.
The general dictum is “Frostbite in January, amputate in July” [25]. Avoid immediate or early amputation. Wait till demarcation is complete to maximise functional outcome [56]. It may take 3 months. However, in cases of wet gangrene or spreading sepsis, early amputation may be unavoidable [83, 84]. For such cases, using MRA/99Tc triple-phase bone scanning is useful in planning the site of amputation [63]. Some authors advocate that coverage with vascularised tissue and free tissue transfer, rather than autograft improves the viability of injured bone, tendon or nerve, if early surgical intervention is done [85, 86].
In case patient develops compartment syndrome, escharotomy or fasciotomy may be indicated in the early phase [25, 56].
For the military, frostbite sequelae constitute an occupational injury with a major career impact. These sequelae may compromise future operational capability of the soldier. This chapter highlights simple and effective treatment steps that all clinicians can perform through every echelon of care and thereby reduce the period in which the patient is unable to perform his or her normal duties as a soldier in a cold environment.
No potential conflict of interest was reported by the authors.
"Open access contributes to scientific excellence and integrity. It opens up research results to wider analysis. It allows research results to be reused for new discoveries. And it enables the multi-disciplinary research that is needed to solve global 21st century problems. Open access connects science with society. It allows the public to engage with research. To go behind the headlines. And look at the scientific evidence. And it enables policy makers to draw on innovative solutions to societal challenges".
\n\nCarlos Moedas, the European Commissioner for Research Science and Innovation at the STM Annual Frankfurt Conference, October 2016.
",metaTitle:"About Open Access",metaDescription:"Open access contributes to scientific excellence and integrity. It opens up research results to wider analysis. It allows research results to be reused for new discoveries. And it enables the multi-disciplinary research that is needed to solve global 21st century problems. Open access connects science with society. It allows the public to engage with research. To go behind the headlines. And look at the scientific evidence. And it enables policy makers to draw on innovative solutions to societal challenges.\n\nCarlos Moedas, the European Commissioner for Research Science and Innovation at the STM Annual Frankfurt Conference, October 2016.",metaKeywords:null,canonicalURL:"about-open-access",contentRaw:'[{"type":"htmlEditorComponent","content":"The Open Access publishing movement started in the early 2000s when academic leaders from around the world participated in the formation of the Budapest Initiative. They developed recommendations for an Open Access publishing process, “which has worked for the past decade to provide the public with unrestricted, free access to scholarly research—much of which is publicly funded. Making the research publicly available to everyone—free of charge and without most copyright and licensing restrictions—will accelerate scientific research efforts and allow authors to reach a larger number of readers” (reference: http://www.budapestopenaccessinitiative.org)
\\n\\nIntechOpen’s co-founders, both scientists themselves, created the company while undertaking research in robotics at Vienna University. Their goal was to spread research freely “for scientists, by scientists’ to the rest of the world via the Open Access publishing model. The company soon became a signatory of the Budapest Initiative, which currently has more than 1000 supporting organizations worldwide, ranging from universities to funders.
\\n\\nAt IntechOpen today, we are still as committed to working with organizations and people who care about scientific discovery, to putting the academic needs of the scientific community first, and to providing an Open Access environment where scientists can maximize their contribution to scientific advancement. By opening up access to the world’s scientific research articles and book chapters, we aim to facilitate greater opportunity for collaboration, scientific discovery and progress. We subscribe wholeheartedly to the Open Access definition:
\\n\\n“By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited” (reference: http://www.budapestopenaccessinitiative.org)
\\n\\nOAI-PMH
\\n\\nAs a firm believer in the wider dissemination of knowledge, IntechOpen supports the Open Access Initiative Protocol for Metadata Harvesting (OAI-PMH Version 2.0). Read more
\\n\\nLicense
\\n\\nBook chapters published in edited volumes are distributed under the Creative Commons Attribution 3.0 Unported License (CC BY 3.0). IntechOpen upholds a very flexible Copyright Policy. There is no copyright transfer to the publisher and Authors retain exclusive copyright to their work. All Monographs/Compacts are distributed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Read more
\\n\\nPeer Review Policies
\\n\\nAll scientific works are Peer Reviewed prior to publishing. Read more
\\n\\nOA Publishing Fees
\\n\\nThe Open Access publishing model employed by IntechOpen eliminates subscription charges and pay-per-view fees, enabling readers to access research at no cost. In order to sustain operations and keep our publications freely accessible we levy an Open Access Publishing Fee for manuscripts, which helps us cover the costs of editorial work and the production of books. Read more
\\n\\nDigital Archiving Policy
\\n\\nIntechOpen is committed to ensuring the long-term preservation and the availability of all scholarly research we publish. We employ a variety of means to enable us to deliver on our commitments to the scientific community. Apart from preservation by the Croatian National Library (for publications prior to April 18, 2018) and the British Library (for publications after April 18, 2018), our entire catalogue is preserved in the CLOCKSS archive.
\\n"}]'},components:[{type:"htmlEditorComponent",content:'The Open Access publishing movement started in the early 2000s when academic leaders from around the world participated in the formation of the Budapest Initiative. They developed recommendations for an Open Access publishing process, “which has worked for the past decade to provide the public with unrestricted, free access to scholarly research—much of which is publicly funded. Making the research publicly available to everyone—free of charge and without most copyright and licensing restrictions—will accelerate scientific research efforts and allow authors to reach a larger number of readers” (reference: http://www.budapestopenaccessinitiative.org)
\n\nIntechOpen’s co-founders, both scientists themselves, created the company while undertaking research in robotics at Vienna University. Their goal was to spread research freely “for scientists, by scientists’ to the rest of the world via the Open Access publishing model. The company soon became a signatory of the Budapest Initiative, which currently has more than 1000 supporting organizations worldwide, ranging from universities to funders.
\n\nAt IntechOpen today, we are still as committed to working with organizations and people who care about scientific discovery, to putting the academic needs of the scientific community first, and to providing an Open Access environment where scientists can maximize their contribution to scientific advancement. By opening up access to the world’s scientific research articles and book chapters, we aim to facilitate greater opportunity for collaboration, scientific discovery and progress. We subscribe wholeheartedly to the Open Access definition:
\n\n“By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited” (reference: http://www.budapestopenaccessinitiative.org)
\n\nOAI-PMH
\n\nAs a firm believer in the wider dissemination of knowledge, IntechOpen supports the Open Access Initiative Protocol for Metadata Harvesting (OAI-PMH Version 2.0). Read more
\n\nLicense
\n\nBook chapters published in edited volumes are distributed under the Creative Commons Attribution 3.0 Unported License (CC BY 3.0). IntechOpen upholds a very flexible Copyright Policy. There is no copyright transfer to the publisher and Authors retain exclusive copyright to their work. All Monographs/Compacts are distributed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Read more
\n\nPeer Review Policies
\n\nAll scientific works are Peer Reviewed prior to publishing. Read more
\n\nOA Publishing Fees
\n\nThe Open Access publishing model employed by IntechOpen eliminates subscription charges and pay-per-view fees, enabling readers to access research at no cost. In order to sustain operations and keep our publications freely accessible we levy an Open Access Publishing Fee for manuscripts, which helps us cover the costs of editorial work and the production of books. Read more
\n\nDigital Archiving Policy
\n\nIntechOpen is committed to ensuring the long-term preservation and the availability of all scholarly research we publish. We employ a variety of means to enable us to deliver on our commitments to the scientific community. Apart from preservation by the Croatian National Library (for publications prior to April 18, 2018) and the British Library (for publications after April 18, 2018), our entire catalogue is preserved in the CLOCKSS archive.
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5822},{group:"region",caption:"Middle and South America",value:2,count:5289},{group:"region",caption:"Africa",value:3,count:1761},{group:"region",caption:"Asia",value:4,count:10546},{group:"region",caption:"Australia and Oceania",value:5,count:909},{group:"region",caption:"Europe",value:6,count:15938}],offset:12,limit:12,total:119319},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"dateEndThirdStepPublish",topicId:"8"},books:[{type:"book",id:"10696",title:"Calorimetry - New Advances",subtitle:null,isOpenForSubmission:!0,hash:"bb239599406f0b731bbfd62c1c8dbf3f",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10696.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10504",title:"Crystallization",subtitle:null,isOpenForSubmission:!0,hash:"3478d05926950f475f4ad2825d340963",slug:null,bookSignature:"Dr. Youssef Ben Smida and Dr. Riadh Marzouki",coverURL:"https://cdn.intechopen.com/books/images_new/10504.jpg",editedByType:null,editors:[{id:"311698",title:"Dr.",name:"Youssef",surname:"Ben Smida",slug:"youssef-ben-smida",fullName:"Youssef Ben Smida"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10697",title:"Raman Spectroscopy",subtitle:null,isOpenForSubmission:!0,hash:"6e2bfc19cc9f0b441890f24485b0de80",slug:null,bookSignature:"Dr. Marianna V. Kharlamova",coverURL:"https://cdn.intechopen.com/books/images_new/10697.jpg",editedByType:null,editors:[{id:"285875",title:"Dr.",name:"Marianna V.",surname:"Kharlamova",slug:"marianna-v.-kharlamova",fullName:"Marianna V. Kharlamova"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10700",title:"Titanium Dioxide",subtitle:null,isOpenForSubmission:!0,hash:"d9448d83caa34d90fd58464268c869a0",slug:null,bookSignature:"Dr. Hafiz Muhammad Ali",coverURL:"https://cdn.intechopen.com/books/images_new/10700.jpg",editedByType:null,editors:[{id:"187624",title:"Dr.",name:"Hafiz Muhammad",surname:"Ali",slug:"hafiz-muhammad-ali",fullName:"Hafiz Muhammad Ali"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10699",title:"Foams",subtitle:null,isOpenForSubmission:!0,hash:"9495e848f41431e0ffb3be12b4d80544",slug:null,bookSignature:"Dr. Marco Caniato",coverURL:"https://cdn.intechopen.com/books/images_new/10699.jpg",editedByType:null,editors:[{id:"312499",title:"Dr.",name:"Marco",surname:"Caniato",slug:"marco-caniato",fullName:"Marco Caniato"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11000",title:"Advances in Mass Transfer",subtitle:null,isOpenForSubmission:!0,hash:"f9cdf245988fe529bcab93c3b1286ba4",slug:null,bookSignature:"Prof. Badie I. Morsi and Dr. Omar M. Basha",coverURL:"https://cdn.intechopen.com/books/images_new/11000.jpg",editedByType:null,editors:[{id:"174420",title:"Prof.",name:"Badie",surname:"Morsi",slug:"badie-morsi",fullName:"Badie Morsi"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10997",title:"Arsenic",subtitle:null,isOpenForSubmission:!0,hash:"a40cc5d83f2f1233db31ef10c547b35c",slug:null,bookSignature:"Dr. Margarita Stoytcheva and Dr. Roumen Zlatev",coverURL:"https://cdn.intechopen.com/books/images_new/10997.jpg",editedByType:null,editors:[{id:"170080",title:"Dr.",name:"Margarita",surname:"Stoytcheva",slug:"margarita-stoytcheva",fullName:"Margarita Stoytcheva"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10698",title:"Elemental Mass Spectrometry - Basic Principles and Analytical Applications",subtitle:null,isOpenForSubmission:!0,hash:"2b139aeb749b1a8d8453a1326b48ff20",slug:null,bookSignature:"Dr. Edgar Pinto and Prof. Agostinho Almeida",coverURL:"https://cdn.intechopen.com/books/images_new/10698.jpg",editedByType:null,editors:[{id:"345122",title:"Dr.",name:"Edgar",surname:"Pinto",slug:"edgar-pinto",fullName:"Edgar Pinto"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10861",title:"Furans and Furan Derivatives - Recent Advances and Applications",subtitle:null,isOpenForSubmission:!0,hash:"fdfc39cecd82f91b0effac994f75c877",slug:null,bookSignature:"Dr. Anish Khan, Prof. Mohammed Muzibur Rahman, Dr. M Ramesh, Dr. Salman Ahmad Khan and Dr. Abdullah M. Asiri",coverURL:"https://cdn.intechopen.com/books/images_new/10861.jpg",editedByType:null,editors:[{id:"293058",title:"Dr.",name:"Anish",surname:"Khan",slug:"anish-khan",fullName:"Anish Khan"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10701",title:"Alkenes - Recent Advances, New Perspectives and Applications",subtitle:null,isOpenForSubmission:!0,hash:"f6dd394ef1ca2d6472220de6a79a0d9a",slug:null,bookSignature:"Dr. Reza Davarnejad",coverURL:"https://cdn.intechopen.com/books/images_new/10701.jpg",editedByType:null,editors:[{id:"88069",title:"Dr.",name:"Reza",surname:"Davarnejad",slug:"reza-davarnejad",fullName:"Reza Davarnejad"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11072",title:"Modern Sample Preparation Techniques",subtitle:null,isOpenForSubmission:!0,hash:"38fecf7570774c29c22a0cbca58ba570",slug:null,bookSignature:"Prof. Massoud Kaykhaii",coverURL:"https://cdn.intechopen.com/books/images_new/11072.jpg",editedByType:null,editors:[{id:"349151",title:"Prof.",name:"Massoud",surname:"Kaykhaii",slug:"massoud-kaykhaii",fullName:"Massoud Kaykhaii"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:28},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:8},{group:"topic",caption:"Business, Management and Economics",value:7,count:4},{group:"topic",caption:"Chemistry",value:8,count:10},{group:"topic",caption:"Computer and Information Science",value:9,count:10},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:10},{group:"topic",caption:"Engineering",value:11,count:26},{group:"topic",caption:"Environmental Sciences",value:12,count:3},{group:"topic",caption:"Immunology and Microbiology",value:13,count:4},{group:"topic",caption:"Materials Science",value:14,count:7},{group:"topic",caption:"Mathematics",value:15,count:3},{group:"topic",caption:"Medicine",value:16,count:51},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:4},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:11},popularBooks:{featuredBooks:[{type:"book",id:"9154",title:"Spinal Deformities in Adolescents, Adults and Older Adults",subtitle:null,isOpenForSubmission:!1,hash:"313f1dffa803b60a14ff1e6966e93d91",slug:"spinal-deformities-in-adolescents-adults-and-older-adults",bookSignature:"Josette Bettany-Saltikov and Gokulakannan Kandasamy",coverURL:"https://cdn.intechopen.com/books/images_new/9154.jpg",editors:[{id:"94802",title:"Dr.",name:"Josette",middleName:null,surname:"Bettany-Saltikov",slug:"josette-bettany-saltikov",fullName:"Josette Bettany-Saltikov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7030",title:"Satellite Systems",subtitle:"Design, Modeling, Simulation and Analysis",isOpenForSubmission:!1,hash:"b9db6d2645ef248ceb1b33ea75f38e88",slug:"satellite-systems-design-modeling-simulation-and-analysis",bookSignature:"Tien Nguyen",coverURL:"https://cdn.intechopen.com/books/images_new/7030.jpg",editors:[{id:"210657",title:"Dr.",name:"Tien M.",middleName:"Manh",surname:"Nguyen",slug:"tien-m.-nguyen",fullName:"Tien M. Nguyen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10201",title:"Post-Transition Metals",subtitle:null,isOpenForSubmission:!1,hash:"cc7f53ff5269916e3ce29f65a51a87ae",slug:"post-transition-metals",bookSignature:"Mohammed Muzibur Rahman, Abdullah Mohammed Asiri, Anish Khan, Inamuddin and Thamer Tabbakh",coverURL:"https://cdn.intechopen.com/books/images_new/10201.jpg",editors:[{id:"24438",title:"Prof.",name:"Mohammed Muzibur",middleName:null,surname:"Rahman",slug:"mohammed-muzibur-rahman",fullName:"Mohammed Muzibur Rahman"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10413",title:"A Collection of Papers on Chaos Theory and Its Applications",subtitle:null,isOpenForSubmission:!1,hash:"900b71b164948830fec3d6254b7881f7",slug:"a-collection-of-papers-on-chaos-theory-and-its-applications",bookSignature:"Paul Bracken and Dimo I. Uzunov",coverURL:"https://cdn.intechopen.com/books/images_new/10413.jpg",editors:[{id:"92883",title:"Prof.",name:"Paul",middleName:null,surname:"Bracken",slug:"paul-bracken",fullName:"Paul Bracken"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8472",title:"Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health",subtitle:null,isOpenForSubmission:!1,hash:"8855452919b8495810ef8e88641feb20",slug:"bioactive-compounds-in-nutraceutical-and-functional-food-for-good-human-health",bookSignature:"Kavita Sharma, Kanchan Mishra, Kula Kamal Senapati and Corina Danciu",coverURL:"https://cdn.intechopen.com/books/images_new/8472.jpg",editors:[{id:"197731",title:"Dr.",name:"Kavita",middleName:null,surname:"Sharma",slug:"kavita-sharma",fullName:"Kavita Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9515",title:"Update in Geriatrics",subtitle:null,isOpenForSubmission:!1,hash:"913e16c0ae977474b283bbd4269564c8",slug:"update-in-geriatrics",bookSignature:"Somchai Amornyotin",coverURL:"https://cdn.intechopen.com/books/images_new/9515.jpg",editors:[{id:"185484",title:"Prof.",name:"Somchai",middleName:null,surname:"Amornyotin",slug:"somchai-amornyotin",fullName:"Somchai Amornyotin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8148",title:"Investment Strategies in Emerging New Trends in Finance",subtitle:null,isOpenForSubmission:!1,hash:"3b714d96a68d2acdfbd7b50aba6504ca",slug:"investment-strategies-in-emerging-new-trends-in-finance",bookSignature:"Reza Gharoie Ahangar and Asma Salman",coverURL:"https://cdn.intechopen.com/books/images_new/8148.jpg",editors:[{id:"91081",title:"Dr.",name:"Reza",middleName:null,surname:"Gharoie Ahangar",slug:"reza-gharoie-ahangar",fullName:"Reza Gharoie Ahangar"}],equalEditorOne:{id:"206443",title:"Prof.",name:"Asma",middleName:null,surname:"Salman",slug:"asma-salman",fullName:"Asma Salman",profilePictureURL:"https://mts.intechopen.com/storage/users/206443/images/system/206443.png",biography:"Professor Asma Salman is a blockchain developer and Professor of Finance at the American University in the Emirates, UAE. An Honorary Global Advisor at the Global Academy of Finance and Management, USA, she completed her MBA in Finance and Accounting and earned a Ph.D. in Finance from an AACSB member, AMBA accredited, School of Management at Harbin Institute of Technology, China. Her research credentials include a one-year residency at the Brunel Business School, Brunel University, UK. Prof. Salman also served as the Dubai Cohort supervisor for DBA students under the Nottingham Business School, UK, for seven years and is currently a Ph.D. supervisor at the University of Northampton, UK, where she is a visiting fellow. She also served on the Board of Etihad Airlines during 2019–2020. One of her recent articles on “Bitcoin and Blockchain” gained wide visibility and she is an active speaker on Fintech, blockchain, and crypto events around the GCC. She holds various professional certifications including Chartered Fintech Professional (USA), Certified Financial Manager (USA), Women in Leadership and Management in Higher Education, (UK), and Taxation GCC VAT Compliance, (UK). She recently won an award for “Blockchain Trainer of the Year” from Berkeley Middle East. Other recognitions include the Women Leadership Impact Award by H.E First Lady of Armenia, Research Excellence Award, and the Global Inspirational Women Leadership Award by H.H Sheikh Juma Bin Maktoum Juma Al Maktoum.",institutionString:"American University in the Emirates",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"American University in the Emirates",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9959",title:"Biomedical Signal and Image Processing",subtitle:null,isOpenForSubmission:!1,hash:"22b87a09bd6df065d78c175235d367c8",slug:"biomedical-signal-and-image-processing",bookSignature:"Yongxia Zhou",coverURL:"https://cdn.intechopen.com/books/images_new/9959.jpg",editors:[{id:"259308",title:"Dr.",name:"Yongxia",middleName:null,surname:"Zhou",slug:"yongxia-zhou",fullName:"Yongxia Zhou"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9685",title:"Agroecosystems",subtitle:"Very Complex Environmental Systems",isOpenForSubmission:!1,hash:"c44f7b43a9f9610c243dc32300d37df6",slug:"agroecosystems-very-complex-environmental-systems",bookSignature:"Marcelo L. Larramendy and Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/9685.jpg",editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9161",title:"Frailty in the Elderly",subtitle:"Understanding and Managing Complexity",isOpenForSubmission:!1,hash:"a4f0f2fade8fb8ba35c405f5ad31a823",slug:"frailty-in-the-elderly-understanding-and-managing-complexity",bookSignature:"Sara Palermo",coverURL:"https://cdn.intechopen.com/books/images_new/9161.jpg",editors:[{id:"233998",title:"Ph.D.",name:"Sara",middleName:null,surname:"Palermo",slug:"sara-palermo",fullName:"Sara Palermo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5330},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9154",title:"Spinal Deformities in Adolescents, Adults and Older Adults",subtitle:null,isOpenForSubmission:!1,hash:"313f1dffa803b60a14ff1e6966e93d91",slug:"spinal-deformities-in-adolescents-adults-and-older-adults",bookSignature:"Josette Bettany-Saltikov and Gokulakannan Kandasamy",coverURL:"https://cdn.intechopen.com/books/images_new/9154.jpg",editors:[{id:"94802",title:"Dr.",name:"Josette",middleName:null,surname:"Bettany-Saltikov",slug:"josette-bettany-saltikov",fullName:"Josette Bettany-Saltikov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7030",title:"Satellite Systems",subtitle:"Design, Modeling, Simulation and Analysis",isOpenForSubmission:!1,hash:"b9db6d2645ef248ceb1b33ea75f38e88",slug:"satellite-systems-design-modeling-simulation-and-analysis",bookSignature:"Tien Nguyen",coverURL:"https://cdn.intechopen.com/books/images_new/7030.jpg",editors:[{id:"210657",title:"Dr.",name:"Tien M.",middleName:"Manh",surname:"Nguyen",slug:"tien-m.-nguyen",fullName:"Tien M. Nguyen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8472",title:"Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health",subtitle:null,isOpenForSubmission:!1,hash:"8855452919b8495810ef8e88641feb20",slug:"bioactive-compounds-in-nutraceutical-and-functional-food-for-good-human-health",bookSignature:"Kavita Sharma, Kanchan Mishra, Kula Kamal Senapati and Corina Danciu",coverURL:"https://cdn.intechopen.com/books/images_new/8472.jpg",editors:[{id:"197731",title:"Dr.",name:"Kavita",middleName:null,surname:"Sharma",slug:"kavita-sharma",fullName:"Kavita Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10201",title:"Post-Transition Metals",subtitle:null,isOpenForSubmission:!1,hash:"cc7f53ff5269916e3ce29f65a51a87ae",slug:"post-transition-metals",bookSignature:"Mohammed Muzibur Rahman, Abdullah Mohammed Asiri, Anish Khan, Inamuddin and Thamer Tabbakh",coverURL:"https://cdn.intechopen.com/books/images_new/10201.jpg",editors:[{id:"24438",title:"Prof.",name:"Mohammed Muzibur",middleName:null,surname:"Rahman",slug:"mohammed-muzibur-rahman",fullName:"Mohammed Muzibur Rahman"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10413",title:"A Collection of Papers on Chaos Theory and Its Applications",subtitle:null,isOpenForSubmission:!1,hash:"900b71b164948830fec3d6254b7881f7",slug:"a-collection-of-papers-on-chaos-theory-and-its-applications",bookSignature:"Paul Bracken and Dimo I. Uzunov",coverURL:"https://cdn.intechopen.com/books/images_new/10413.jpg",editors:[{id:"92883",title:"Prof.",name:"Paul",middleName:null,surname:"Bracken",slug:"paul-bracken",fullName:"Paul Bracken"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9515",title:"Update in Geriatrics",subtitle:null,isOpenForSubmission:!1,hash:"913e16c0ae977474b283bbd4269564c8",slug:"update-in-geriatrics",bookSignature:"Somchai Amornyotin",coverURL:"https://cdn.intechopen.com/books/images_new/9515.jpg",editors:[{id:"185484",title:"Prof.",name:"Somchai",middleName:null,surname:"Amornyotin",slug:"somchai-amornyotin",fullName:"Somchai Amornyotin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8148",title:"Investment Strategies in Emerging New Trends in Finance",subtitle:null,isOpenForSubmission:!1,hash:"3b714d96a68d2acdfbd7b50aba6504ca",slug:"investment-strategies-in-emerging-new-trends-in-finance",bookSignature:"Reza Gharoie Ahangar and Asma Salman",coverURL:"https://cdn.intechopen.com/books/images_new/8148.jpg",editors:[{id:"91081",title:"Dr.",name:"Reza",middleName:null,surname:"Gharoie Ahangar",slug:"reza-gharoie-ahangar",fullName:"Reza Gharoie Ahangar"}],equalEditorOne:{id:"206443",title:"Prof.",name:"Asma",middleName:null,surname:"Salman",slug:"asma-salman",fullName:"Asma Salman",profilePictureURL:"https://mts.intechopen.com/storage/users/206443/images/system/206443.png",biography:"Professor Asma Salman is a blockchain developer and Professor of Finance at the American University in the Emirates, UAE. An Honorary Global Advisor at the Global Academy of Finance and Management, USA, she completed her MBA in Finance and Accounting and earned a Ph.D. in Finance from an AACSB member, AMBA accredited, School of Management at Harbin Institute of Technology, China. Her research credentials include a one-year residency at the Brunel Business School, Brunel University, UK. Prof. Salman also served as the Dubai Cohort supervisor for DBA students under the Nottingham Business School, UK, for seven years and is currently a Ph.D. supervisor at the University of Northampton, UK, where she is a visiting fellow. She also served on the Board of Etihad Airlines during 2019–2020. One of her recent articles on “Bitcoin and Blockchain” gained wide visibility and she is an active speaker on Fintech, blockchain, and crypto events around the GCC. She holds various professional certifications including Chartered Fintech Professional (USA), Certified Financial Manager (USA), Women in Leadership and Management in Higher Education, (UK), and Taxation GCC VAT Compliance, (UK). She recently won an award for “Blockchain Trainer of the Year” from Berkeley Middle East. Other recognitions include the Women Leadership Impact Award by H.E First Lady of Armenia, Research Excellence Award, and the Global Inspirational Women Leadership Award by H.H Sheikh Juma Bin Maktoum Juma Al Maktoum.",institutionString:"American University in the Emirates",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"American University in the Emirates",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3568",title:"Recent Advances in Plant in vitro Culture",subtitle:null,isOpenForSubmission:!1,hash:"830bbb601742c85a3fb0eeafe1454c43",slug:"recent-advances-in-plant-in-vitro-culture",bookSignature:"Annarita Leva and Laura M. R. Rinaldi",coverURL:"https://cdn.intechopen.com/books/images_new/3568.jpg",editors:[{id:"142145",title:"Dr.",name:"Annarita",middleName:null,surname:"Leva",slug:"annarita-leva",fullName:"Annarita Leva"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9515",title:"Update in Geriatrics",subtitle:null,isOpenForSubmission:!1,hash:"913e16c0ae977474b283bbd4269564c8",slug:"update-in-geriatrics",bookSignature:"Somchai Amornyotin",coverURL:"https://cdn.intechopen.com/books/images_new/9515.jpg",editedByType:"Edited by",editors:[{id:"185484",title:"Prof.",name:"Somchai",middleName:null,surname:"Amornyotin",slug:"somchai-amornyotin",fullName:"Somchai Amornyotin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9021",title:"Novel Perspectives of Stem Cell Manufacturing and Therapies",subtitle:null,isOpenForSubmission:!1,hash:"522c6db871783d2a11c17b83f1fd4e18",slug:"novel-perspectives-of-stem-cell-manufacturing-and-therapies",bookSignature:"Diana Kitala and Ana Colette Maurício",coverURL:"https://cdn.intechopen.com/books/images_new/9021.jpg",editedByType:"Edited by",editors:[{id:"203598",title:"Ph.D.",name:"Diana",middleName:null,surname:"Kitala",slug:"diana-kitala",fullName:"Diana Kitala"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7030",title:"Satellite Systems",subtitle:"Design, Modeling, Simulation and Analysis",isOpenForSubmission:!1,hash:"b9db6d2645ef248ceb1b33ea75f38e88",slug:"satellite-systems-design-modeling-simulation-and-analysis",bookSignature:"Tien Nguyen",coverURL:"https://cdn.intechopen.com/books/images_new/7030.jpg",editedByType:"Edited by",editors:[{id:"210657",title:"Dr.",name:"Tien M.",middleName:"Manh",surname:"Nguyen",slug:"tien-m.-nguyen",fullName:"Tien M. Nguyen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10413",title:"A Collection of Papers on Chaos Theory and Its Applications",subtitle:null,isOpenForSubmission:!1,hash:"900b71b164948830fec3d6254b7881f7",slug:"a-collection-of-papers-on-chaos-theory-and-its-applications",bookSignature:"Paul Bracken and Dimo I. Uzunov",coverURL:"https://cdn.intechopen.com/books/images_new/10413.jpg",editedByType:"Edited by",editors:[{id:"92883",title:"Prof.",name:"Paul",middleName:null,surname:"Bracken",slug:"paul-bracken",fullName:"Paul Bracken"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9154",title:"Spinal Deformities in Adolescents, Adults and Older Adults",subtitle:null,isOpenForSubmission:!1,hash:"313f1dffa803b60a14ff1e6966e93d91",slug:"spinal-deformities-in-adolescents-adults-and-older-adults",bookSignature:"Josette Bettany-Saltikov and Gokulakannan Kandasamy",coverURL:"https://cdn.intechopen.com/books/images_new/9154.jpg",editedByType:"Edited by",editors:[{id:"94802",title:"Dr.",name:"Josette",middleName:null,surname:"Bettany-Saltikov",slug:"josette-bettany-saltikov",fullName:"Josette Bettany-Saltikov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8148",title:"Investment Strategies in Emerging New Trends in Finance",subtitle:null,isOpenForSubmission:!1,hash:"3b714d96a68d2acdfbd7b50aba6504ca",slug:"investment-strategies-in-emerging-new-trends-in-finance",bookSignature:"Reza Gharoie Ahangar and Asma Salman",coverURL:"https://cdn.intechopen.com/books/images_new/8148.jpg",editedByType:"Edited by",editors:[{id:"91081",title:"Dr.",name:"Reza",middleName:null,surname:"Gharoie Ahangar",slug:"reza-gharoie-ahangar",fullName:"Reza Gharoie Ahangar"}],equalEditorOne:{id:"206443",title:"Prof.",name:"Asma",middleName:null,surname:"Salman",slug:"asma-salman",fullName:"Asma Salman",profilePictureURL:"https://mts.intechopen.com/storage/users/206443/images/system/206443.png",biography:"Professor Asma Salman is a blockchain developer and Professor of Finance at the American University in the Emirates, UAE. An Honorary Global Advisor at the Global Academy of Finance and Management, USA, she completed her MBA in Finance and Accounting and earned a Ph.D. in Finance from an AACSB member, AMBA accredited, School of Management at Harbin Institute of Technology, China. Her research credentials include a one-year residency at the Brunel Business School, Brunel University, UK. Prof. Salman also served as the Dubai Cohort supervisor for DBA students under the Nottingham Business School, UK, for seven years and is currently a Ph.D. supervisor at the University of Northampton, UK, where she is a visiting fellow. She also served on the Board of Etihad Airlines during 2019–2020. One of her recent articles on “Bitcoin and Blockchain” gained wide visibility and she is an active speaker on Fintech, blockchain, and crypto events around the GCC. She holds various professional certifications including Chartered Fintech Professional (USA), Certified Financial Manager (USA), Women in Leadership and Management in Higher Education, (UK), and Taxation GCC VAT Compliance, (UK). She recently won an award for “Blockchain Trainer of the Year” from Berkeley Middle East. Other recognitions include the Women Leadership Impact Award by H.E First Lady of Armenia, Research Excellence Award, and the Global Inspirational Women Leadership Award by H.H Sheikh Juma Bin Maktoum Juma Al Maktoum.",institutionString:"American University in the Emirates",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"American University in the Emirates",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10201",title:"Post-Transition Metals",subtitle:null,isOpenForSubmission:!1,hash:"cc7f53ff5269916e3ce29f65a51a87ae",slug:"post-transition-metals",bookSignature:"Mohammed Muzibur Rahman, Abdullah Mohammed Asiri, Anish Khan, Inamuddin and Thamer Tabbakh",coverURL:"https://cdn.intechopen.com/books/images_new/10201.jpg",editedByType:"Edited by",editors:[{id:"24438",title:"Prof.",name:"Mohammed Muzibur",middleName:null,surname:"Rahman",slug:"mohammed-muzibur-rahman",fullName:"Mohammed Muzibur Rahman"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9959",title:"Biomedical Signal and Image Processing",subtitle:null,isOpenForSubmission:!1,hash:"22b87a09bd6df065d78c175235d367c8",slug:"biomedical-signal-and-image-processing",bookSignature:"Yongxia Zhou",coverURL:"https://cdn.intechopen.com/books/images_new/9959.jpg",editedByType:"Edited by",editors:[{id:"259308",title:"Dr.",name:"Yongxia",middleName:null,surname:"Zhou",slug:"yongxia-zhou",fullName:"Yongxia Zhou"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8472",title:"Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health",subtitle:null,isOpenForSubmission:!1,hash:"8855452919b8495810ef8e88641feb20",slug:"bioactive-compounds-in-nutraceutical-and-functional-food-for-good-human-health",bookSignature:"Kavita Sharma, Kanchan Mishra, Kula Kamal Senapati and Corina Danciu",coverURL:"https://cdn.intechopen.com/books/images_new/8472.jpg",editedByType:"Edited by",editors:[{id:"197731",title:"Dr.",name:"Kavita",middleName:null,surname:"Sharma",slug:"kavita-sharma",fullName:"Kavita Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8760",title:"Structure Topology and Symplectic Geometry",subtitle:null,isOpenForSubmission:!1,hash:"8974840985ec3652492c83e20233bf02",slug:"structure-topology-and-symplectic-geometry",bookSignature:"Kamal Shah and Min Lei",coverURL:"https://cdn.intechopen.com/books/images_new/8760.jpg",editedByType:"Edited by",editors:[{id:"231748",title:"Dr.",name:"Kamal",middleName:null,surname:"Shah",slug:"kamal-shah",fullName:"Kamal Shah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"984",title:"Cardiac Surgery",slug:"cardiac-surgery",parent:{title:"Cardiology and Cardiovascular Medicine",slug:"cardiology-and-cardiovascular-medicine"},numberOfBooks:6,numberOfAuthorsAndEditors:154,numberOfWosCitations:43,numberOfCrossrefCitations:39,numberOfDimensionsCitations:80,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"cardiac-surgery",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"9060",title:"The Current Perspectives on Coronary Artery Bypass Grafting",subtitle:null,isOpenForSubmission:!1,hash:"cedc3547eae8f66f9440cc35216d7963",slug:"the-current-perspectives-on-coronary-artery-bypass-grafting",bookSignature:"Takashi Murashita",coverURL:"https://cdn.intechopen.com/books/images_new/9060.jpg",editedByType:"Edited by",editors:[{id:"192448",title:"Dr.",name:"Takashi",middleName:null,surname:"Murashita",slug:"takashi-murashita",fullName:"Takashi Murashita"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8819",title:"Cardiac Surgery Procedures",subtitle:null,isOpenForSubmission:!1,hash:"3d84cc6e6750d835e4b86578dfdbbdd9",slug:"cardiac-surgery-procedures",bookSignature:"Andrea Montalto, Antonio Loforte and Cristiano Amarelli",coverURL:"https://cdn.intechopen.com/books/images_new/8819.jpg",editedByType:"Edited by",editors:[{id:"222866",title:"Dr.",name:"Andrea",middleName:null,surname:"Montalto",slug:"andrea-montalto",fullName:"Andrea Montalto"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8218",title:"Aortic Stenosis",subtitle:"Current Perspectives",isOpenForSubmission:!1,hash:"d9a81a576f7026e76fa6d29c27b308a6",slug:"aortic-stenosis-current-perspectives",bookSignature:"Peter Magnusson",coverURL:"https://cdn.intechopen.com/books/images_new/8218.jpg",editedByType:"Edited by",editors:[{id:"188088",title:"Dr.",name:"Peter",middleName:null,surname:"Magnusson",slug:"peter-magnusson",fullName:"Peter Magnusson"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6558",title:"Heart Transplantation",subtitle:null,isOpenForSubmission:!1,hash:"fa6adc2ed66fd8de1500ed382fd80f7a",slug:"heart-transplantation",bookSignature:"Antonio Loforte, Andrea Montalto and Cristiano Amarelli",coverURL:"https://cdn.intechopen.com/books/images_new/6558.jpg",editedByType:"Edited by",editors:[{id:"42172",title:"Dr.",name:"Antonio",middleName:null,surname:"Loforte",slug:"antonio-loforte",fullName:"Antonio Loforte"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6556",title:"Advanced Concepts in Endocarditis",subtitle:null,isOpenForSubmission:!1,hash:"2bbeca8acf93c99a265e3a81166a2833",slug:"advanced-concepts-in-endocarditis",bookSignature:"Michael S. Firstenberg",coverURL:"https://cdn.intechopen.com/books/images_new/6556.jpg",editedByType:"Edited by",editors:[{id:"64343",title:null,name:"Michael S.",middleName:null,surname:"Firstenberg",slug:"michael-s.-firstenberg",fullName:"Michael S. Firstenberg"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3542",title:"Artery Bypass",subtitle:null,isOpenForSubmission:!1,hash:"6b48ec67e1291ca98f3aded6a9af92ca",slug:"artery-bypass",bookSignature:"Wilbert S. Aronow",coverURL:"https://cdn.intechopen.com/books/images_new/3542.jpg",editedByType:"Edited by",editors:[{id:"164597",title:"Dr.",name:"Wilbert S.",middleName:null,surname:"Aronow",slug:"wilbert-s.-aronow",fullName:"Wilbert S. Aronow"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:6,mostCitedChapters:[{id:"43500",doi:"10.5772/54723",title:"Pharmacology of Arterial Grafts for Coronary Artery Bypass Surgery",slug:"pharmacology-of-arterial-grafts-for-coronary-artery-bypass-surgery",totalDownloads:2587,totalCrossrefCites:9,totalDimensionsCites:18,book:{slug:"artery-bypass",title:"Artery Bypass",fullTitle:"Artery Bypass"},signatures:"Oguzhan Yildiz, Melik Seyrek and Husamettin Gul",authors:[{id:"164299",title:"Prof.",name:"Oguzhan",middleName:null,surname:"Yıldız",slug:"oguzhan-yildiz",fullName:"Oguzhan Yıldız"},{id:"164968",title:"Dr.",name:"Melik",middleName:null,surname:"Seyrek",slug:"melik-seyrek",fullName:"Melik Seyrek"},{id:"164969",title:"Dr.",name:"Husamettin",middleName:null,surname:"Gul",slug:"husamettin-gul",fullName:"Husamettin Gul"}]},{id:"43514",doi:"10.5772/54418",title:"The Role of The Angiosome Model in Treatment of Critical Limb Ischemia",slug:"the-role-of-the-angiosome-model-in-treatment-of-critical-limb-ischemia",totalDownloads:3339,totalCrossrefCites:4,totalDimensionsCites:10,book:{slug:"artery-bypass",title:"Artery Bypass",fullTitle:"Artery Bypass"},signatures:"Kim Houlind and Johnny Christensen",authors:[{id:"165363",title:"Associate Prof.",name:"Kim",middleName:null,surname:"Houlind",slug:"kim-houlind",fullName:"Kim Houlind"},{id:"167383",title:"Dr.",name:"Johnny",middleName:null,surname:"Christensen",slug:"johnny-christensen",fullName:"Johnny Christensen"}]},{id:"43476",doi:"10.5772/54509",title:"Impact of Ischemia on Cellular Metabolism",slug:"impact-of-ischemia-on-cellular-metabolism",totalDownloads:2340,totalCrossrefCites:2,totalDimensionsCites:6,book:{slug:"artery-bypass",title:"Artery Bypass",fullTitle:"Artery Bypass"},signatures:"Maximilien Gourdin and Philippe Dubois",authors:[{id:"164978",title:"Prof.",name:"Philippe",middleName:"E",surname:"Dubois",slug:"philippe-dubois",fullName:"Philippe Dubois"},{id:"164982",title:"Dr.",name:"Maximilien",middleName:null,surname:"Gourdin",slug:"maximilien-gourdin",fullName:"Maximilien Gourdin"}]}],mostDownloadedChaptersLast30Days:[{id:"63351",title:"Anesthesia and Intensive Care Management for Cardiac Transplantation",slug:"anesthesia-and-intensive-care-management-for-cardiac-transplantation",totalDownloads:878,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"heart-transplantation",title:"Heart Transplantation",fullTitle:"Heart Transplantation"},signatures:"Massimo Baiocchi, Maria Benedetto, Marta Agulli and Guido\nFrascaroli",authors:[{id:"235369",title:"Dr.",name:"Massimo",middleName:null,surname:"Baiocchi",slug:"massimo-baiocchi",fullName:"Massimo Baiocchi"},{id:"271188",title:"Dr.",name:"Maria",middleName:null,surname:"Benedetto",slug:"maria-benedetto",fullName:"Maria Benedetto"},{id:"271189",title:"Dr.",name:"Marta",middleName:null,surname:"Agulli",slug:"marta-agulli",fullName:"Marta Agulli"},{id:"271190",title:"Dr.",name:"Guido",middleName:null,surname:"Frascaroli",slug:"guido-frascaroli",fullName:"Guido Frascaroli"}]},{id:"72679",title:"Tips and Tricks in Microvascular Anastomoses",slug:"tips-and-tricks-in-microvascular-anastomoses",totalDownloads:316,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"the-current-perspectives-on-coronary-artery-bypass-grafting",title:"The Current Perspectives on Coronary Artery Bypass Grafting",fullTitle:"The Current Perspectives on Coronary Artery Bypass Grafting"},signatures:"Sharifah Ahmad Roohi",authors:[{id:"214913",title:"Prof.",name:"S.A.",middleName:null,surname:"Roohi",slug:"s.a.-roohi",fullName:"S.A. Roohi"}]},{id:"67354",title:"Cannulation for Cardiopulmonary Bypass",slug:"cannulation-for-cardiopulmonary-bypass",totalDownloads:539,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"cardiac-surgery-procedures",title:"Cardiac Surgery Procedures",fullTitle:"Cardiac Surgery Procedures"},signatures:"Emily Bond, Crystal Valadon and Mark Slaughter",authors:null},{id:"65984",title:"Low Flow Low Gradient Severe Aortic Stenosis: Diagnosis and Treatment",slug:"low-flow-low-gradient-severe-aortic-stenosis-diagnosis-and-treatment",totalDownloads:1328,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"aortic-stenosis-current-perspectives",title:"Aortic Stenosis",fullTitle:"Aortic Stenosis - Current Perspectives"},signatures:"Faeez Mohamad Ali, Vindhya Wilson and Rajesh Nair",authors:[{id:"280651",title:"Dr.",name:"Rajesh",middleName:null,surname:"Nair",slug:"rajesh-nair",fullName:"Rajesh Nair"},{id:"280829",title:"Dr.",name:"Faeez",middleName:null,surname:"Mohamad Ali",slug:"faeez-mohamad-ali",fullName:"Faeez Mohamad Ali"},{id:"290351",title:"Dr.",name:"Vindhya",middleName:null,surname:"Wilson",slug:"vindhya-wilson",fullName:"Vindhya Wilson"}]},{id:"59628",title:"Endocarditis Caused by Abiotrophia and Granulicatella Species",slug:"endocarditis-caused-by-abiotrophia-and-granulicatella-species",totalDownloads:624,totalCrossrefCites:1,totalDimensionsCites:3,book:{slug:"advanced-concepts-in-endocarditis",title:"Advanced Concepts in Endocarditis",fullTitle:"Advanced Concepts in Endocarditis"},signatures:"Gul Madison, Reshma Golamari and Priyanka Bhattacharya",authors:[{id:"232406",title:"M.D.",name:"Priyanka",middleName:null,surname:"Bhattacharya",slug:"priyanka-bhattacharya",fullName:"Priyanka Bhattacharya"},{id:"232407",title:"Dr.",name:"Reshma",middleName:null,surname:"Golamari",slug:"reshma-golamari",fullName:"Reshma Golamari"},{id:"234923",title:"Dr.",name:"Gul",middleName:null,surname:"Madison",slug:"gul-madison",fullName:"Gul Madison"}]},{id:"66972",title:"Aortic Stenosis in Dogs and Cats: Past, Present and Future",slug:"aortic-stenosis-in-dogs-and-cats-past-present-and-future",totalDownloads:772,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"aortic-stenosis-current-perspectives",title:"Aortic Stenosis",fullTitle:"Aortic Stenosis - Current Perspectives"},signatures:"Aleksandra Domanjko Petrič, Anja Perovič, Tanja Švara and Peter Dovč",authors:[{id:"155868",title:"Ph.D.",name:"Aleksandra",middleName:null,surname:"Domanjko Petrič",slug:"aleksandra-domanjko-petric",fullName:"Aleksandra Domanjko Petrič"},{id:"186261",title:"Prof.",name:"Peter",middleName:null,surname:"Dovč",slug:"peter-dovc",fullName:"Peter Dovč"},{id:"293885",title:"BSc.",name:"Anja",middleName:null,surname:"Perovič",slug:"anja-perovic",fullName:"Anja Perovič"},{id:"293886",title:"Dr.",name:"Tanja",middleName:null,surname:"Švara",slug:"tanja-svara",fullName:"Tanja Švara"}]},{id:"61397",title:"The Ethics in Repeat Heart Valve Replacement Surgery",slug:"the-ethics-in-repeat-heart-valve-replacement-surgery",totalDownloads:700,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"advanced-concepts-in-endocarditis",title:"Advanced Concepts in Endocarditis",fullTitle:"Advanced Concepts in Endocarditis"},signatures:"Julie M. Aultman, Emanuela Peshel, Cyril Harfouche and Michael S.\nFirstenberg",authors:[{id:"64343",title:null,name:"Michael S.",middleName:null,surname:"Firstenberg",slug:"michael-s.-firstenberg",fullName:"Michael S. Firstenberg"},{id:"227150",title:"Ms.",name:"Emanuela",middleName:null,surname:"Peshel",slug:"emanuela-peshel",fullName:"Emanuela Peshel"},{id:"229719",title:"Dr.",name:"Julie",middleName:"M.",surname:"Aultman",slug:"julie-aultman",fullName:"Julie Aultman"},{id:"232060",title:"Mr.",name:"Cyril",middleName:null,surname:"Harfouche",slug:"cyril-harfouche",fullName:"Cyril Harfouche"}]},{id:"42945",title:"Total Arterial Revascularization in Coronary Artery Bypass Grafting Surgery",slug:"total-arterial-revascularization-in-coronary-artery-bypass-grafting-surgery",totalDownloads:2072,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"artery-bypass",title:"Artery Bypass",fullTitle:"Artery Bypass"},signatures:"Sean Maddock, Gilbert H. L. Tang, Wilbert S. Aronow and Ramin Malekan",authors:[{id:"164597",title:"Dr.",name:"Wilbert S.",middleName:null,surname:"Aronow",slug:"wilbert-s.-aronow",fullName:"Wilbert S. Aronow"},{id:"165464",title:"Mr.",name:"Sean",middleName:null,surname:"Maddock",slug:"sean-maddock",fullName:"Sean Maddock"},{id:"165465",title:"Dr.",name:"Gilbert L.",middleName:null,surname:"Tang",slug:"gilbert-l.-tang",fullName:"Gilbert L. Tang"},{id:"165466",title:"Dr.",name:"Ramin",middleName:null,surname:"Malekan",slug:"ramin-malekan",fullName:"Ramin Malekan"}]},{id:"43600",title:"Surgical Treatment for Diffuse Coronary Artery Diseases",slug:"surgical-treatment-for-diffuse-coronary-artery-diseases",totalDownloads:2785,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"artery-bypass",title:"Artery Bypass",fullTitle:"Artery Bypass"},signatures:"Xiong Gu-Cheng, Yang Yu and Chuan Wang",authors:[{id:"164379",title:"Dr.",name:"Cheng-Xiong",middleName:null,surname:"Gu",slug:"cheng-xiong-gu",fullName:"Cheng-Xiong Gu"},{id:"164767",title:"Dr.",name:"Yang",middleName:null,surname:"Yu",slug:"yang-yu",fullName:"Yang Yu"},{id:"167382",title:"Dr.",name:"Chuan",middleName:null,surname:"Wang",slug:"chuan-wang",fullName:"Chuan Wang"}]},{id:"61419",title:"Heart Transplantation in the Era of the Left Ventricular Assist Devices",slug:"heart-transplantation-in-the-era-of-the-left-ventricular-assist-devices",totalDownloads:1029,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"heart-transplantation",title:"Heart Transplantation",fullTitle:"Heart Transplantation"},signatures:"Michael Mazzei, Suresh Keshavamurthy, Abul Kashem and Yoshiya\nToyoda",authors:[{id:"179835",title:"Dr.",name:"Yoshiya",middleName:null,surname:"Toyoda",slug:"yoshiya-toyoda",fullName:"Yoshiya Toyoda"},{id:"243073",title:"Dr.",name:"Suresh",middleName:null,surname:"Keshavamurthy",slug:"suresh-keshavamurthy",fullName:"Suresh Keshavamurthy"},{id:"244735",title:"Dr.",name:"Michael",middleName:null,surname:"Mazzei",slug:"michael-mazzei",fullName:"Michael Mazzei"},{id:"244736",title:"Dr.",name:"Abul",middleName:null,surname:"Kashem",slug:"abul-kashem",fullName:"Abul Kashem"}]}],onlineFirstChaptersFilter:{topicSlug:"cardiac-surgery",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"onlineFirst.detail",path:"/online-first/frostbite-a-conundrum-in-high-altitudes",hash:"",query:{},params:{chapter:"frostbite-a-conundrum-in-high-altitudes"},fullPath:"/online-first/frostbite-a-conundrum-in-high-altitudes",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()